| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | granulocyte colony-stimulating factor receptor binding | 5.04e-08 | 14 | 328 | 6 | GO:0005130 | |
| GeneOntologyMolecularFunction | Toll-like receptor binding | 3.46e-07 | 29 | 328 | 7 | GO:0035325 | |
| GeneOntologyMolecularFunction | GPI anchor binding | 1.50e-06 | 23 | 328 | 6 | GO:0034235 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 3.01e-06 | 73 | 328 | 9 | GO:0170055 | |
| GeneOntologyMolecularFunction | filamin binding | 6.48e-06 | 29 | 328 | 6 | GO:0031005 | |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 1.71e-05 | 34 | 328 | 6 | GO:0015125 | |
| GeneOntologyMolecularFunction | CDP phosphatase activity | 1.74e-05 | 4 | 328 | 3 | GO:0036384 | |
| GeneOntologyMolecularFunction | amino acid binding | 2.59e-05 | 73 | 328 | 8 | GO:0016597 | |
| GeneOntologyMolecularFunction | calmodulin binding | PSG2 PSG3 PSG4 PSG5 MYO10 PSG9 PSG11 SPTAN1 SPTBN1 SYT1 NOS1 WFS1 CDK5RAP2 PNCK | 2.90e-05 | 230 | 328 | 14 | GO:0005516 |
| GeneOntologyMolecularFunction | ankyrin binding | 3.06e-05 | 23 | 328 | 5 | GO:0030506 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 1.17e-04 | 90 | 328 | 8 | GO:0008028 | |
| GeneOntologyMolecularFunction | glycolipid binding | 1.45e-04 | 49 | 328 | 6 | GO:0051861 | |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 1.49e-04 | 70 | 328 | 7 | GO:1901618 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | KIF21B ATP8B4 ABCB7 ABCF1 RTEL1 MYO7B MYO10 TOMM20 MCM6 SRCAP ABCA9 UBA7 ACSF3 CHD6 ABCC1 SMARCAL1 WRN MORC4 MFSD2A ENTPD1 MACF1 TOP2A TOP2B | 2.23e-04 | 614 | 328 | 23 | GO:0140657 |
| GeneOntologyMolecularFunction | DNA topoisomerase activity | 2.31e-04 | 8 | 328 | 3 | GO:0003916 | |
| GeneOntologyMolecularFunction | glutamate decarboxylase activity | 2.69e-04 | 2 | 328 | 2 | GO:0004351 | |
| GeneOntologyMolecularFunction | intracellular sodium-activated potassium channel activity | 2.69e-04 | 2 | 328 | 2 | GO:0005228 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | SMG1 TRPM7 FGFRL1 SNRK ACVR2A PANK1 MAP3K4 CHUK JAK1 MAST4 PIK3CB MAP3K15 MERTK RIOK1 PANK3 AAK1 LRRK1 GUCY2D DCLK3 PNCK MST1L PRKDC ATM ALPK2 IPMK | 3.00e-04 | 709 | 328 | 25 | GO:0016773 |
| GeneOntologyMolecularFunction | UDP phosphatase activity | 3.43e-04 | 9 | 328 | 3 | GO:0045134 | |
| GeneOntologyMolecularFunction | kinase activity | SMG1 TRPM7 FGFRL1 SNRK ACVR2A PANK1 MAP3K4 CHUK JAK1 MAST4 PIK3CB MAP3K15 MERTK RIOK1 PANK3 AAK1 MAGI3 LRRK1 GUCY2D DCLK3 PNCK MST1L PRKDC ATM ALPK2 IPMK | 3.92e-04 | 764 | 328 | 26 | GO:0016301 |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | SMG1 TRPM7 FGFRL1 SNRK ACVR2A PANK1 MAP3K4 CHUK JAK1 MAST4 PAPOLA PIK3CB PARP16 MAP3K15 MERTK RIOK1 PANK3 POLD1 AAK1 MAGI3 LRRK1 PAPOLG GUCY2D DCLK3 PNCK MST1L PRKDC ATM ALPK2 IPMK | 4.02e-04 | 938 | 328 | 30 | GO:0016772 |
| GeneOntologyMolecularFunction | protein kinase activity | SMG1 TRPM7 FGFRL1 SNRK ACVR2A MAP3K4 CHUK JAK1 MAST4 PIK3CB MAP3K15 MERTK RIOK1 AAK1 LRRK1 GUCY2D DCLK3 PNCK MST1L PRKDC ATM ALPK2 | 4.08e-04 | 600 | 328 | 22 | GO:0004672 |
| GeneOntologyMolecularFunction | lipid transporter activity | ATP8B4 PSG2 PSG3 PSG4 PSG5 PSG9 PSG11 SLCO4A1 ABCA9 ABCC1 MFSD2A | 4.14e-04 | 196 | 328 | 11 | GO:0005319 |
| GeneOntologyMolecularFunction | phosphatase binding | PSG2 PSG3 PSG4 PSG5 PSG9 PSG11 JAK1 NFATC2 ANAPC5 MAGI3 SMG5 SPTBN4 CD22 | 4.51e-04 | 264 | 328 | 13 | GO:0019902 |
| GeneOntologyMolecularFunction | telomeric DNA binding | 4.76e-04 | 40 | 328 | 5 | GO:0042162 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | KIF21B TRPM7 PSG2 PSG3 MYO7B PSG4 PSG5 MYO10 STRBP PSG9 PSG11 SPTAN1 SPTBN1 EML6 TUBGCP2 NEB DYSF S100B SYNE2 CLTC GNB3 RHCG CORO2A CAPN2 RHAG SPTBN4 PPP5C XIRP2 KIRREL1 MACF1 CDK5RAP2 FHDC1 EML1 | 6.26e-04 | 1099 | 328 | 33 | GO:0008092 |
| GeneOntologyMolecularFunction | carbohydrate binding | MAN2C1 GALNT1 FREM1 CEMIP2 LMAN2L C4A LMAN2 C4B GPI KRT1 CD22 TKT CRYBG3 LY75 | 6.52e-04 | 310 | 328 | 14 | GO:0030246 |
| GeneOntologyMolecularFunction | protein phosphatase binding | 7.37e-04 | 210 | 328 | 11 | GO:0019903 | |
| GeneOntologyMolecularFunction | DNA-dependent protein kinase activity | 7.98e-04 | 3 | 328 | 2 | GO:0004677 | |
| GeneOntologyMolecularFunction | histone H2AXS139 kinase activity | 7.98e-04 | 3 | 328 | 2 | GO:0035979 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase binding | 8.15e-04 | 149 | 328 | 9 | GO:1990782 | |
| GeneOntologyMolecularFunction | GDP phosphatase activity | 8.65e-04 | 12 | 328 | 3 | GO:0004382 | |
| GeneOntologyMolecularFunction | actin binding | TRPM7 PSG2 PSG3 MYO7B PSG4 PSG5 MYO10 PSG9 PSG11 SPTAN1 SPTBN1 NEB SYNE2 CORO2A SPTBN4 XIRP2 MACF1 FHDC1 | 1.03e-03 | 479 | 328 | 18 | GO:0003779 |
| GeneOntologyMolecularFunction | protein serine kinase activity | SMG1 TRPM7 SNRK MAP3K4 MAST4 PIK3CB MAP3K15 RIOK1 AAK1 LRRK1 DCLK3 PNCK PRKDC ATM ALPK2 | 1.05e-03 | 363 | 328 | 15 | GO:0106310 |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 1.20e-03 | 127 | 328 | 8 | GO:0008094 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | SMG1 TRPM7 SNRK ACVR2A MAP3K4 CHUK MAST4 PIK3CB MAP3K15 RIOK1 AAK1 LRRK1 DCLK3 PNCK PRKDC ATM ALPK2 | 1.21e-03 | 446 | 328 | 17 | GO:0004674 |
| GeneOntologyMolecularFunction | glutamate binding | 1.40e-03 | 14 | 328 | 3 | GO:0016595 | |
| GeneOntologyMolecularFunction | vitamin binding | 1.41e-03 | 161 | 328 | 9 | GO:0019842 | |
| GeneOntologyMolecularFunction | carbon dioxide transmembrane transporter activity | 1.58e-03 | 4 | 328 | 2 | GO:0035379 | |
| GeneOntologyMolecularFunction | DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity | 1.58e-03 | 4 | 328 | 2 | GO:0003918 | |
| GeneOntologyMolecularFunction | pantothenate kinase activity | 1.58e-03 | 4 | 328 | 2 | GO:0004594 | |
| GeneOntologyMolecularFunction | acetyl-CoA binding | 1.58e-03 | 4 | 328 | 2 | GO:1905502 | |
| GeneOntologyMolecularFunction | carboxylic acid binding | UBR1 GAD1 GAD2 ACACB GLDC SARDH NOS1 COL11A1 GRIN2B CD22 MTR | 2.08e-03 | 239 | 328 | 11 | GO:0031406 |
| GeneOntologyMolecularFunction | spectrin binding | 2.25e-03 | 34 | 328 | 4 | GO:0030507 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | PDXDC1 SEPTIN9 SPTAN1 SPTBN1 DSCAML1 CEMIP2 NRXN3 FN1 TNC ICAM2 GRIN2B LRRC4C SND1 KIRREL1 MACF1 CD151 CDH6 CDH11 PHLDB2 HDLBP | 2.26e-03 | 599 | 328 | 20 | GO:0050839 |
| GeneOntologyMolecularFunction | calcium-dependent cysteine-type endopeptidase activity | 2.52e-03 | 17 | 328 | 3 | GO:0004198 | |
| GeneOntologyMolecularFunction | histone H2AX kinase activity | 2.60e-03 | 5 | 328 | 2 | GO:0141003 | |
| GeneOntologyMolecularFunction | IDP phosphatase activity | 2.60e-03 | 5 | 328 | 2 | GO:1990003 | |
| GeneOntologyBiologicalProcess | negative regulation of brown fat cell proliferation | 4.02e-08 | 14 | 326 | 6 | GO:0070348 | |
| GeneOntologyBiologicalProcess | regulation of brown fat cell proliferation | 6.61e-08 | 15 | 326 | 6 | GO:0070347 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immune response to tumor cell | 6.61e-08 | 15 | 326 | 6 | GO:0002856 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 6.61e-08 | 15 | 326 | 6 | GO:0002859 | |
| GeneOntologyBiologicalProcess | positive regulation of homophilic cell adhesion | 6.61e-08 | 15 | 326 | 6 | GO:1903387 | |
| GeneOntologyBiologicalProcess | insulin receptor internalization | 1.04e-07 | 16 | 326 | 6 | GO:0038016 | |
| GeneOntologyBiologicalProcess | brown fat cell proliferation | 1.59e-07 | 17 | 326 | 6 | GO:0070342 | |
| GeneOntologyBiologicalProcess | insulin catabolic process | 1.59e-07 | 17 | 326 | 6 | GO:1901143 | |
| GeneOntologyBiologicalProcess | granulocyte colony-stimulating factor signaling pathway | 1.59e-07 | 17 | 326 | 6 | GO:0038158 | |
| GeneOntologyBiologicalProcess | regulation of homophilic cell adhesion | 2.36e-07 | 18 | 326 | 6 | GO:1903385 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | DCHS2 PCDHA9 PSG2 PSG3 PSG4 PSG5 PSG9 PSG11 DSCAML1 PIK3CB PCDHA12 PCDHA11 PCDHA3 CDH6 CDH11 | 3.09e-07 | 187 | 326 | 15 | GO:0007156 |
| GeneOntologyBiologicalProcess | negative regulation of hepatocyte proliferation | 4.79e-07 | 20 | 326 | 6 | GO:2000346 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | DCHS2 PCDHA9 PSG2 PSG3 PSG4 PSG5 PSG9 PSG11 FGFRL1 DSCAML1 PIK3CB UNC5D PCDHA12 PCDHA11 LRRC4B PCDHA3 LRRC4C CDH6 CDH11 | 6.54e-07 | 313 | 326 | 19 | GO:0098742 |
| GeneOntologyBiologicalProcess | negative regulation of fat cell proliferation | 6.61e-07 | 21 | 326 | 6 | GO:0070345 | |
| GeneOntologyBiologicalProcess | negative regulation of response to tumor cell | 6.61e-07 | 21 | 326 | 6 | GO:0002835 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response to tumor cell | 6.61e-07 | 21 | 326 | 6 | GO:0002838 | |
| GeneOntologyBiologicalProcess | negative regulation of vascular permeability | 8.61e-07 | 34 | 326 | 7 | GO:0043116 | |
| GeneOntologyBiologicalProcess | negative regulation of granulocyte differentiation | 8.97e-07 | 22 | 326 | 6 | GO:0030853 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 1.20e-06 | 23 | 326 | 6 | GO:0002858 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet aggregation | 1.20e-06 | 23 | 326 | 6 | GO:0090331 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immune response to tumor cell | 1.58e-06 | 24 | 326 | 6 | GO:0002855 | |
| GeneOntologyBiologicalProcess | positive regulation of vasculogenesis | 1.58e-06 | 24 | 326 | 6 | GO:2001214 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity directed against tumor cell target | 1.58e-06 | 24 | 326 | 6 | GO:0002420 | |
| GeneOntologyBiologicalProcess | common myeloid progenitor cell proliferation | 2.05e-06 | 25 | 326 | 6 | GO:0035726 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immune response to tumor cell | 2.05e-06 | 25 | 326 | 6 | GO:0002423 | |
| GeneOntologyBiologicalProcess | regulation of fat cell proliferation | 3.33e-06 | 27 | 326 | 6 | GO:0070344 | |
| GeneOntologyBiologicalProcess | negative regulation of osteoclast differentiation | 3.93e-06 | 59 | 326 | 8 | GO:0045671 | |
| GeneOntologyBiologicalProcess | negative regulation of homotypic cell-cell adhesion | 4.18e-06 | 28 | 326 | 6 | GO:0034111 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid metabolic process | 4.47e-06 | 60 | 326 | 8 | GO:0045922 | |
| GeneOntologyBiologicalProcess | regulation of vasculogenesis | 5.20e-06 | 29 | 326 | 6 | GO:2001212 | |
| GeneOntologyBiologicalProcess | negative regulation of behavior | 6.26e-06 | 45 | 326 | 7 | GO:0048521 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet activation | 7.85e-06 | 31 | 326 | 6 | GO:0010544 | |
| GeneOntologyBiologicalProcess | regulation of sprouting angiogenesis | 7.91e-06 | 85 | 326 | 9 | GO:1903670 | |
| GeneOntologyBiologicalProcess | fat cell proliferation | 9.54e-06 | 32 | 326 | 6 | GO:0070341 | |
| GeneOntologyBiologicalProcess | negative regulation of bone resorption | 9.54e-06 | 32 | 326 | 6 | GO:0045779 | |
| GeneOntologyBiologicalProcess | regulation of blood vessel remodeling | 9.54e-06 | 32 | 326 | 6 | GO:0060312 | |
| GeneOntologyBiologicalProcess | negative regulation of feeding behavior | 1.15e-05 | 33 | 326 | 6 | GO:2000252 | |
| GeneOntologyBiologicalProcess | regulation of granulocyte differentiation | 1.15e-05 | 33 | 326 | 6 | GO:0030852 | |
| GeneOntologyBiologicalProcess | small molecule catabolic process | GAD1 GAD2 ACACB AKR1D1 ADA PRODH2 GLB1 GLDC ALDH1L2 ACSF3 SARDH ALDH6A1 NOS1 GPI ENTPD4 MFSD2A LIPE HAGH HADHA PCCB | 1.37e-05 | 421 | 326 | 20 | GO:0044282 |
| GeneOntologyBiologicalProcess | negative regulation of bone remodeling | 1.38e-05 | 34 | 326 | 6 | GO:0046851 | |
| GeneOntologyBiologicalProcess | telomere maintenance | SMG1 RTEL1 MAP3K4 USP7 SMG6 SMARCAL1 WRN SMG5 DCLRE1C YLPM1 PRKDC ATM | 1.55e-05 | 168 | 326 | 12 | GO:0000723 |
| GeneOntologyBiologicalProcess | regulation of vascular permeability | 1.60e-05 | 71 | 326 | 8 | GO:0043114 | |
| GeneOntologyBiologicalProcess | insulin metabolic process | 1.64e-05 | 35 | 326 | 6 | GO:1901142 | |
| GeneOntologyBiologicalProcess | regulation of homotypic cell-cell adhesion | 1.91e-05 | 53 | 326 | 7 | GO:0034110 | |
| GeneOntologyBiologicalProcess | regulation of hepatocyte proliferation | 2.68e-05 | 38 | 326 | 6 | GO:2000345 | |
| GeneOntologyBiologicalProcess | organic acid catabolic process | GAD1 GAD2 ACACB AKR1D1 PRODH2 GLDC ALDH1L2 ACSF3 SARDH ALDH6A1 NOS1 MFSD2A LIPE HADHA PCCB | 3.07e-05 | 272 | 326 | 15 | GO:0016054 |
| GeneOntologyBiologicalProcess | carboxylic acid catabolic process | GAD1 GAD2 ACACB AKR1D1 PRODH2 GLDC ALDH1L2 ACSF3 SARDH ALDH6A1 NOS1 MFSD2A LIPE HADHA PCCB | 3.07e-05 | 272 | 326 | 15 | GO:0046395 |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid biosynthetic process | 3.13e-05 | 39 | 326 | 6 | GO:0045717 | |
| GeneOntologyBiologicalProcess | negative regulation of response to wounding | 3.23e-05 | 126 | 326 | 10 | GO:1903035 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity | 3.63e-05 | 40 | 326 | 6 | GO:0045953 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immunity | 4.20e-05 | 41 | 326 | 6 | GO:0002716 | |
| GeneOntologyBiologicalProcess | telomere capping | 4.20e-05 | 41 | 326 | 6 | GO:0016233 | |
| GeneOntologyBiologicalProcess | regulation of platelet aggregation | 4.83e-05 | 42 | 326 | 6 | GO:0090330 | |
| GeneOntologyBiologicalProcess | regulation of feeding behavior | 4.85e-05 | 61 | 326 | 7 | GO:0060259 | |
| GeneOntologyBiologicalProcess | regulation of telomere capping | 5.80e-05 | 27 | 326 | 5 | GO:1904353 | |
| GeneOntologyBiologicalProcess | negative regulation of myeloid leukocyte differentiation | 5.98e-05 | 85 | 326 | 8 | GO:0002762 | |
| GeneOntologyBiologicalProcess | telomere organization | SMG1 RTEL1 MAP3K4 USP7 SMG6 SMARCAL1 WRN SMG5 DCLRE1C YLPM1 PRKDC ATM | 8.18e-05 | 199 | 326 | 12 | GO:0032200 |
| GeneOntologyBiologicalProcess | epithelial cell proliferation involved in liver morphogenesis | 8.19e-05 | 46 | 326 | 6 | GO:0072575 | |
| GeneOntologyBiologicalProcess | hepatocyte proliferation | 8.19e-05 | 46 | 326 | 6 | GO:0072574 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated cytotoxicity | 9.26e-05 | 47 | 326 | 6 | GO:0001911 | |
| GeneOntologyBiologicalProcess | bile acid and bile salt transport | 9.26e-05 | 47 | 326 | 6 | GO:0015721 | |
| GeneOntologyBiologicalProcess | negative regulation of tissue remodeling | 9.26e-05 | 47 | 326 | 6 | GO:0034104 | |
| GeneOntologyBiologicalProcess | negative regulation of lipid metabolic process | 1.06e-04 | 145 | 326 | 10 | GO:0045833 | |
| GeneOntologyBiologicalProcess | carboxylic acid metabolic process | PDXDC1 GAD1 GAD2 ACACB PSG2 PSG3 PSG4 PSG5 PSG9 PSG11 AKR1D1 GMPS PRODH2 NFE2L1 GLDC ALDH1L2 ACSF3 GAPDHS SARDH ALDH6A1 NOS1 GPI ABCC1 SLC25A16 MFSD2A LIPE ASS1 MTR SLC45A2 HAGH HADHA PCCB ABHD12 | 1.07e-04 | 1035 | 326 | 33 | GO:0019752 |
| GeneOntologyBiologicalProcess | negative regulation of blood coagulation | 1.08e-04 | 69 | 326 | 7 | GO:0030195 | |
| GeneOntologyBiologicalProcess | regulation of immune response to tumor cell | 1.17e-04 | 49 | 326 | 6 | GO:0002837 | |
| GeneOntologyBiologicalProcess | liver morphogenesis | 1.17e-04 | 49 | 326 | 6 | GO:0072576 | |
| GeneOntologyBiologicalProcess | regulation of bone resorption | 1.18e-04 | 70 | 326 | 7 | GO:0045124 | |
| GeneOntologyBiologicalProcess | negative regulation of hemostasis | 1.18e-04 | 70 | 326 | 7 | GO:1900047 | |
| GeneOntologyBiologicalProcess | gland morphogenesis | 1.30e-04 | 178 | 326 | 11 | GO:0022612 | |
| GeneOntologyBiologicalProcess | regulation of response to tumor cell | 1.32e-04 | 50 | 326 | 6 | GO:0002834 | |
| GeneOntologyBiologicalProcess | platelet aggregation | 1.32e-04 | 95 | 326 | 8 | GO:0070527 | |
| GeneOntologyBiologicalProcess | glycosaminoglycan metabolic process | 1.32e-04 | 121 | 326 | 9 | GO:0030203 | |
| GeneOntologyBiologicalProcess | negative regulation of small molecule metabolic process | 1.33e-04 | 149 | 326 | 10 | GO:0062014 | |
| GeneOntologyBiologicalProcess | negative regulation of coagulation | 1.41e-04 | 72 | 326 | 7 | GO:0050819 | |
| GeneOntologyBiologicalProcess | purine nucleotide biosynthetic process | ACACB NDUFA1 ADA PANK1 ADCY2 GMPS PARP16 ACSF3 NOS1 PANK3 APRT SLC25A16 GUCY2D ENTPD1 | 1.59e-04 | 280 | 326 | 14 | GO:0006164 |
| GeneOntologyBiologicalProcess | homotypic cell-cell adhesion | 1.59e-04 | 124 | 326 | 9 | GO:0034109 | |
| GeneOntologyBiologicalProcess | oxoacid metabolic process | PDXDC1 GAD1 GAD2 ACACB PSG2 PSG3 PSG4 PSG5 PSG9 PSG11 AKR1D1 GMPS PRODH2 NFE2L1 GLDC ALDH1L2 ACSF3 GAPDHS SARDH ALDH6A1 NOS1 GPI ABCC1 SLC25A16 MFSD2A LIPE ASS1 MTR SLC45A2 HAGH HADHA PCCB ABHD12 | 1.61e-04 | 1058 | 326 | 33 | GO:0043436 |
| GeneOntologyBiologicalProcess | negative regulation of wound healing | 1.64e-04 | 98 | 326 | 8 | GO:0061045 | |
| GeneOntologyBiologicalProcess | negative regulation of cell killing | 1.64e-04 | 52 | 326 | 6 | GO:0031342 | |
| GeneOntologyBiologicalProcess | mRNA export from nucleus | 1.68e-04 | 74 | 326 | 7 | GO:0006406 | |
| GeneOntologyBiologicalProcess | bone resorption | 1.76e-04 | 99 | 326 | 8 | GO:0045453 | |
| GeneOntologyBiologicalProcess | organic acid metabolic process | PDXDC1 GAD1 GAD2 ACACB PSG2 PSG3 PSG4 PSG5 PSG9 PSG11 AKR1D1 GMPS PRODH2 NFE2L1 GLDC ALDH1L2 ACSF3 GAPDHS SARDH ALDH6A1 NOS1 GPI ABCC1 SLC25A16 MFSD2A LIPE ASS1 MTR SLC45A2 HAGH HADHA PCCB ABHD12 | 1.79e-04 | 1064 | 326 | 33 | GO:0006082 |
| GeneOntologyBiologicalProcess | mucopolysaccharide metabolic process | 1.88e-04 | 100 | 326 | 8 | GO:1903510 | |
| GeneOntologyBiologicalProcess | bone remodeling | 1.91e-04 | 127 | 326 | 9 | GO:0046849 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity | 1.99e-04 | 76 | 326 | 7 | GO:0042269 | |
| GeneOntologyBiologicalProcess | purine-containing compound biosynthetic process | ACACB NDUFA1 ADA PANK1 ADCY2 GMPS PARP16 ACSF3 NOS1 PANK3 APRT SLC25A16 GUCY2D ENTPD1 | 2.13e-04 | 288 | 326 | 14 | GO:0072522 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | DCHS2 PCDHA9 PSG2 PSG3 PSG4 HLA-DPA1 PSG5 MYO10 PSG9 PSG11 FGFRL1 ADA DSCAML1 JAK1 SERPINB8 NRXN3 PIK3CB PLEKHA7 AP3D1 UNC5D ICAM2 PCDHA12 PCDHA11 LRRC4B PCDHA3 LRRC4C ENTPD1 ASS1 CD44 LRP6 KIRREL1 CDH6 CDH11 | 2.23e-04 | 1077 | 326 | 33 | GO:0098609 |
| GeneOntologyBiologicalProcess | dicarboxylic acid catabolic process | 2.43e-04 | 20 | 326 | 4 | GO:0043649 | |
| GeneOntologyBiologicalProcess | immune response to tumor cell | 2.49e-04 | 56 | 326 | 6 | GO:0002418 | |
| GeneOntologyBiologicalProcess | regulation of Wnt signaling pathway involved in heart development | 2.49e-04 | 2 | 326 | 2 | GO:0003307 | |
| GeneOntologyBiologicalProcess | negative regulation of Wnt signaling pathway involved in heart development | 2.49e-04 | 2 | 326 | 2 | GO:0003308 | |
| GeneOntologyBiologicalProcess | gamma-aminobutyrate shunt | 2.49e-04 | 2 | 326 | 2 | GO:0006540 | |
| GeneOntologyBiologicalProcess | positive regulation of single stranded viral RNA replication via double stranded DNA intermediate | 2.49e-04 | 2 | 326 | 2 | GO:0045870 | |
| GeneOntologyBiologicalProcess | aminoglycan metabolic process | 2.55e-04 | 132 | 326 | 9 | GO:0006022 | |
| GeneOntologyBiologicalProcess | osteoclast differentiation | 2.63e-04 | 162 | 326 | 10 | GO:0030316 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immunity | 2.73e-04 | 80 | 326 | 7 | GO:0002715 | |
| GeneOntologyBiologicalProcess | regulation of bone remodeling | 2.73e-04 | 80 | 326 | 7 | GO:0046850 | |
| GeneOntologyBiologicalProcess | regulation of fatty acid metabolic process | 2.85e-04 | 134 | 326 | 9 | GO:0019217 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte proliferation | 2.85e-04 | 134 | 326 | 9 | GO:0070664 | |
| GeneOntologyCellularComponent | transforming growth factor beta ligand-receptor complex | 9.47e-08 | 16 | 325 | 6 | GO:0070021 | |
| GeneOntologyCellularComponent | clathrin-sculpted gamma-aminobutyric acid transport vesicle | 3.82e-06 | 8 | 325 | 4 | GO:0061200 | |
| GeneOntologyCellularComponent | clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane | 3.82e-06 | 8 | 325 | 4 | GO:0061202 | |
| GeneOntologyCellularComponent | serine/threonine protein kinase complex | TBKBP1 PSG2 PSG3 PSG4 PSG5 PSG9 PSG11 ACVR2A CHUK IKBKG PRKDC | 3.61e-05 | 157 | 325 | 11 | GO:1902554 |
| GeneOntologyCellularComponent | protein kinase complex | TBKBP1 PSG2 PSG3 PSG4 PSG5 PSG9 PSG11 ACVR2A CHUK IKBKG PRKDC | 7.45e-05 | 170 | 325 | 11 | GO:1902911 |
| GeneOntologyCellularComponent | lateral plasma membrane | 8.03e-05 | 90 | 325 | 8 | GO:0016328 | |
| GeneOntologyCellularComponent | clathrin-sculpted vesicle | 9.01e-05 | 16 | 325 | 4 | GO:0060198 | |
| GeneOntologyCellularComponent | ciliary membrane | 1.46e-04 | 98 | 325 | 8 | GO:0060170 | |
| GeneOntologyCellularComponent | cell projection membrane | PSG2 PSG3 PSG4 PSG5 MYO10 PSG9 PSG11 SPTBN1 STX4 PIK3CB SYNE2 GPI GUCY2D CD44 LRP2 PLEKHA1 KIRREL1 MACF1 | 1.55e-04 | 431 | 325 | 18 | GO:0031253 |
| GeneOntologyCellularComponent | transferase complex, transferring phosphorus-containing groups | TBKBP1 PSG2 PSG3 PSG4 PSG5 PSG9 PSG11 ACVR2A CHUK PIK3CB POLD1 IKBKG TAF6L PRKDC TAF5L | 2.60e-04 | 335 | 325 | 15 | GO:0061695 |
| GeneOntologyCellularComponent | spectrin | 2.92e-04 | 9 | 325 | 3 | GO:0008091 | |
| GeneOntologyCellularComponent | clathrin-coated vesicle | GAD1 GAD2 HLA-DPA1 PANK1 KIAA0319 CLTC SYT1 HEATR5B SCAMP1 AAK1 LRP2 DNAJC5 | 3.57e-04 | 237 | 325 | 12 | GO:0030136 |
| GeneOntologyCellularComponent | coated vesicle | GAD1 GAD2 HLA-DPA1 PANK1 KIAA0319 LMAN2L CLTC SYT1 LMAN2 HEATR5B SCAMP1 AAK1 TMED4 LRP2 DNAJC5 | 5.54e-04 | 360 | 325 | 15 | GO:0030135 |
| GeneOntologyCellularComponent | basement membrane | 6.50e-04 | 122 | 325 | 8 | GO:0005604 | |
| GeneOntologyCellularComponent | anchoring junction | RPL27 DCHS2 PSG2 PSG3 PSG4 PSG5 PSG9 PSG11 SPTAN1 FGFRL1 ADA DOCK5 JAK1 SYNE2 CLTC KAZN PLEKHA7 TNC CAPN2 PCDHA12 MAGI3 SPTBN4 XIRP2 CD44 KIRREL1 CD151 CDH6 CDH11 PHLDB2 | 6.76e-04 | 976 | 325 | 29 | GO:0070161 |
| GeneOntologyCellularComponent | fatty acid beta-oxidation multienzyme complex | 7.16e-04 | 3 | 325 | 2 | GO:0036125 | |
| GeneOntologyCellularComponent | mitochondrial fatty acid beta-oxidation multienzyme complex | 7.16e-04 | 3 | 325 | 2 | GO:0016507 | |
| GeneOntologyCellularComponent | nuclear speck | EPOR RTEL1 ALKBH5 NCBP3 FAM76A KAZN HEATR5B CASC3 SRSF4 SRSF6 WRN API5 PASD1 DNAJC11 YLPM1 TAF5L | 1.25e-03 | 431 | 325 | 16 | GO:0016607 |
| MousePheno | decreased susceptibility to Coronaviridae infection | 2.57e-08 | 28 | 256 | 8 | MP:0020950 | |
| MousePheno | abnormal fatty acid oxidation | 4.20e-08 | 54 | 256 | 10 | MP:0010953 | |
| MousePheno | increased skeletal muscle triglyceride level | 5.94e-08 | 21 | 256 | 7 | MP:0031415 | |
| MousePheno | abnormal lipid oxidation | 1.41e-07 | 61 | 256 | 10 | MP:0010951 | |
| MousePheno | decreased fatty acid oxidation | 1.69e-07 | 24 | 256 | 7 | MP:0014172 | |
| MousePheno | abnormal muscle triglyceride level | 2.20e-07 | 36 | 256 | 8 | MP:0031412 | |
| MousePheno | decreased susceptibility to Coronaviridae infection induced morbidity/mortality | 3.72e-07 | 17 | 256 | 6 | MP:0031047 | |
| MousePheno | insulin resistance | PDE3B PSG2 PSG3 PSG4 PSG5 PSG9 PSG11 STX4 PIK3CB NOS1 LCMT1 WRN LIPE LRP6 HADHA ATM | 6.87e-07 | 197 | 256 | 16 | MP:0005331 |
| MousePheno | decreased respiratory quotient | GAD2 ACACB PSG2 PSG3 PSG4 PSG5 STRBP PSG9 PSG11 NDUFA1 CNOT6L PPP5C | 7.89e-07 | 110 | 256 | 12 | MP:0010379 |
| MousePheno | microphthalmia | MYO10 SPTAN1 VPS26C ACVR2A FREM1 CHUK QSOX1 FREM2 TRPM3 CNTRL AGPS ARHGAP35 MORC4 GRM3 MFSD2A TKT LRP2 LRP6 KIRREL1 CDK5RAP2 PCCB TOP2A | 8.76e-07 | 362 | 256 | 22 | MP:0001297 |
| MousePheno | abnormal skeletal muscle triglyceride level | 1.15e-06 | 31 | 256 | 7 | MP:0031413 | |
| MousePheno | abnormal eye size | MYO10 SPTAN1 VPS26C ACVR2A FREM1 CHUK QSOX1 FREM2 TRPM3 CNTRL AGPS ARHGAP35 MORC4 GRM3 MFSD2A TKT LRP2 LRP6 KIRREL1 CDK5RAP2 PCCB TOP2A | 1.58e-06 | 375 | 256 | 22 | MP:0002697 |
| MousePheno | abnormal susceptibility to Coronaviridae infection | 2.67e-06 | 49 | 256 | 8 | MP:0020948 | |
| MousePheno | decreased skeletal muscle cell glucose uptake | 2.76e-06 | 35 | 256 | 7 | MP:0031618 | |
| MousePheno | abnormal respiratory quotient | GAD2 ACACB PSG2 PSG3 PSG4 PSG5 STRBP PSG9 PSG11 NDUFA1 APRT MFSD2A CNOT6L PPP5C | 5.04e-06 | 178 | 256 | 14 | MP:0004129 |
| MousePheno | decreased muscle cell glucose uptake | 5.93e-06 | 39 | 256 | 7 | MP:0030022 | |
| MousePheno | increased abdominal fat pad weight | 7.62e-06 | 27 | 256 | 6 | MP:0009286 | |
| MousePheno | decreased susceptibility to Riboviria infection induced morbidity/mortality | 1.37e-05 | 44 | 256 | 7 | MP:0031023 | |
| MousePheno | decreased carbon dioxide production | 1.78e-05 | 31 | 256 | 6 | MP:0008964 | |
| MousePheno | decreased susceptibility to Riboviria infection | 1.84e-05 | 82 | 256 | 9 | MP:0020914 | |
| MousePheno | increased insulin secretion | 2.07e-05 | 64 | 256 | 8 | MP:0003058 | |
| MousePheno | abnormal skeletal muscle cell glucose uptake | 2.14e-05 | 47 | 256 | 7 | MP:0031617 | |
| MousePheno | decreased cellular glucose uptake | 4.78e-05 | 53 | 256 | 7 | MP:0003926 | |
| MousePheno | polyphagia | 1.05e-04 | 80 | 256 | 8 | MP:0001433 | |
| MousePheno | decreased susceptibility to viral infection induced morbidity/mortality | 1.07e-04 | 60 | 256 | 7 | MP:0009790 | |
| MousePheno | abnormal carbon dioxide production | 2.17e-04 | 67 | 256 | 7 | MP:0008962 | |
| MousePheno | abnormal muscle cell glucose uptake | 2.17e-04 | 67 | 256 | 7 | MP:0004130 | |
| MousePheno | abnormal oxygen consumption | ACACB PSG2 PSG3 PSG4 PSG5 PSG9 PSG11 NDUFA1 NOS1 WFS1 LIPE CNOT6L | 2.54e-04 | 195 | 256 | 12 | MP:0005288 |
| MousePheno | abnormal brain ventricle morphology | SPTAN1 FGFRL1 ATXN1 GLDC KATNIP ADAMTS3 LRRC4B ARHGAP35 ADGRA2 ARHGAP5 WDR11 LRP2 CDK5RAP2 EML1 TP73 | 2.59e-04 | 286 | 256 | 15 | MP:0000822 |
| MousePheno | abnormal glycogen homeostasis | 3.18e-04 | 144 | 256 | 10 | MP:0005438 | |
| MousePheno | abnormal testis development | 3.57e-04 | 34 | 256 | 5 | MP:0003830 | |
| MousePheno | abnormal vascular wound healing | 3.70e-04 | 73 | 256 | 7 | MP:0004883 | |
| MousePheno | omphalocele | 3.97e-04 | 53 | 256 | 6 | MP:0003052 | |
| MousePheno | abnormal circulating leptin level | ACACB PSG2 PSG3 PSG4 PSG5 PSG9 PSG11 PIK3CB HRH1 WFS1 LIPE ATM BBS12 | 4.17e-04 | 236 | 256 | 13 | MP:0005667 |
| Domain | Cadherin | DCHS2 PCDHA9 FREM1 KIAA0319 FREM2 PCDHA12 PCDHA11 PCDHA3 FREM3 CDH6 CDH11 | 6.83e-06 | 118 | 325 | 11 | IPR002126 |
| Domain | IG | PSG2 PSG3 PSG4 PSG5 PSG7 PSG9 PSG11 FGFRL1 DSCAML1 CD300C NCR1 MERTK UNC5D LILRB3 LRRC4B LRRC4C ADGRA2 BTN3A2 CD22 KIRREL1 ALPK2 | 1.67e-05 | 421 | 325 | 21 | SM00409 |
| Domain | Ig_sub | PSG2 PSG3 PSG4 PSG5 PSG7 PSG9 PSG11 FGFRL1 DSCAML1 CD300C NCR1 MERTK UNC5D LILRB3 LRRC4B LRRC4C ADGRA2 BTN3A2 CD22 KIRREL1 ALPK2 | 1.67e-05 | 421 | 325 | 21 | IPR003599 |
| Domain | IGc2 | PSG2 PSG3 PSG4 PSG5 PSG7 PSG9 PSG11 FGFRL1 DSCAML1 UNC5D LRRC4B LRRC4C CD22 KIRREL1 ALPK2 | 1.67e-05 | 235 | 325 | 15 | SM00408 |
| Domain | Ig_sub2 | PSG2 PSG3 PSG4 PSG5 PSG7 PSG9 PSG11 FGFRL1 DSCAML1 UNC5D LRRC4B LRRC4C CD22 KIRREL1 ALPK2 | 1.67e-05 | 235 | 325 | 15 | IPR003598 |
| Domain | Ig-like_fold | EPOR PSG2 PSG3 PSG4 HLA-DPA1 PSG5 PSG7 PSG9 PSG11 FGFRL1 DSCAML1 CD300C KIAA0319 NFATC2 NCR1 MERTK UNC5D SECTM1 LILRB3 FN1 TNC ICAM2 LRRC4B LRRC4C ADGRA2 BTN3A2 CD22 KIRREL1 ALPK2 | 1.78e-05 | 706 | 325 | 29 | IPR013783 |
| Domain | IG_LIKE | PSG2 PSG3 PSG4 HLA-DPA1 PSG5 PSG7 PSG9 PSG11 FGFRL1 DSCAML1 CD300C NCR1 MERTK UNC5D LILRB3 ICAM2 LRRC4B LRRC4C ADGRA2 BTN3A2 CD22 KIRREL1 ALPK2 | 1.81e-05 | 491 | 325 | 23 | PS50835 |
| Domain | Toprim_domain | 2.06e-05 | 4 | 325 | 3 | IPR006171 | |
| Domain | TOPRIM | 2.06e-05 | 4 | 325 | 3 | PS50880 | |
| Domain | Toprim | 2.06e-05 | 4 | 325 | 3 | PF01751 | |
| Domain | Ig-like_dom | PSG2 PSG3 PSG4 HLA-DPA1 PSG5 PSG7 PSG9 PSG11 FGFRL1 DSCAML1 CD300C NCR1 MERTK UNC5D LILRB3 ICAM2 LRRC4B LRRC4C ADGRA2 BTN3A2 CD22 KIRREL1 ALPK2 | 2.64e-05 | 503 | 325 | 23 | IPR007110 |
| Domain | ig | PSG2 PSG3 PSG4 PSG5 PSG7 PSG9 PSG11 FGFRL1 DSCAML1 MERTK UNC5D LILRB3 CD22 | 2.97e-05 | 190 | 325 | 13 | PF00047 |
| Domain | Immunoglobulin | PSG2 PSG3 PSG4 PSG5 PSG7 PSG9 PSG11 FGFRL1 DSCAML1 MERTK UNC5D LILRB3 CD22 | 2.97e-05 | 190 | 325 | 13 | IPR013151 |
| Domain | Ig_2 | 3.88e-05 | 73 | 325 | 8 | PF13895 | |
| Domain | Spectrin | 4.02e-05 | 23 | 325 | 5 | PF00435 | |
| Domain | - | EPOR PSG2 PSG3 PSG4 HLA-DPA1 PSG5 PSG7 PSG9 PSG11 FGFRL1 DSCAML1 CD300C NFATC2 NCR1 MERTK UNC5D SECTM1 FN1 TNC ICAM2 LRRC4B LRRC4C ADGRA2 BTN3A2 CD22 KIRREL1 ALPK2 | 4.06e-05 | 663 | 325 | 27 | 2.60.40.10 |
| Domain | FATC | 5.09e-05 | 5 | 325 | 3 | PF02260 | |
| Domain | FATC_dom | 1.00e-04 | 6 | 325 | 3 | IPR003152 | |
| Domain | FATC | 1.00e-04 | 6 | 325 | 3 | SM01343 | |
| Domain | FAT | 1.00e-04 | 6 | 325 | 3 | PS51189 | |
| Domain | FATC | 1.00e-04 | 6 | 325 | 3 | PS51190 | |
| Domain | PIK_FAT | 1.00e-04 | 6 | 325 | 3 | IPR014009 | |
| Domain | PI3/4_kinase_CS | 1.06e-04 | 15 | 325 | 4 | IPR018936 | |
| Domain | Spectrin_repeat | 1.30e-04 | 29 | 325 | 5 | IPR002017 | |
| Domain | PI3Kc | 1.39e-04 | 16 | 325 | 4 | SM00146 | |
| Domain | - | 1.39e-04 | 16 | 325 | 4 | 1.10.1070.11 | |
| Domain | Ig_V-set | PSG2 PSG3 PSG4 PSG5 PSG7 PSG9 PSG11 DSCAML1 CD300C LRRC4C BTN3A2 KIRREL1 | 1.99e-04 | 199 | 325 | 12 | IPR013106 |
| Domain | SPEC | 2.12e-04 | 32 | 325 | 5 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 2.12e-04 | 32 | 325 | 5 | IPR018159 | |
| Domain | Kinase-like_dom | SMG1 TRPM7 SNRK ACVR2A MAP3K4 CHUK JAK1 MAST4 PIK3CB MAP3K15 MERTK RIOK1 AAK1 LRRK1 ARHGAP35 GUCY2D DCLK3 MACF1 PNCK PRKDC ATM ALPK2 | 2.21e-04 | 542 | 325 | 22 | IPR011009 |
| Domain | PI3/4_kinase_cat_dom | 2.27e-04 | 18 | 325 | 4 | IPR000403 | |
| Domain | PI3_PI4_kinase | 2.27e-04 | 18 | 325 | 4 | PF00454 | |
| Domain | PI3_4_KINASE_1 | 2.27e-04 | 18 | 325 | 4 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 2.27e-04 | 18 | 325 | 4 | PS00916 | |
| Domain | PI3_4_KINASE_3 | 2.27e-04 | 18 | 325 | 4 | PS50290 | |
| Domain | TPR-like_helical_dom | TTC34 COPS2 CLTC SEL1L3 ANAPC5 SMG6 WFS1 TTC27 SMG5 AIP WDR19 PPP5C PRKDC | 2.34e-04 | 233 | 325 | 13 | IPR011990 |
| Domain | WD40_repeat_dom | KIF21B KNTC1 EML6 WDR76 HERC1 GNB3 WDR48 CORO2A LRRK1 WDR19 WDR11 DNAI4 TAF5L EML1 TBL2 | 2.35e-04 | 297 | 325 | 15 | IPR017986 |
| Domain | MacrogloblnA2_thiol-ester-bond | 2.74e-04 | 8 | 325 | 3 | IPR019565 | |
| Domain | GDA1_CD39_NTPase | 2.74e-04 | 8 | 325 | 3 | IPR000407 | |
| Domain | Thiol-ester_cl | 2.74e-04 | 8 | 325 | 3 | PF10569 | |
| Domain | GDA1_CD39 | 2.74e-04 | 8 | 325 | 3 | PF01150 | |
| Domain | Pyridoxal_deC | 2.74e-04 | 8 | 325 | 3 | PF00282 | |
| Domain | PyrdxlP-dep_de-COase | 2.74e-04 | 8 | 325 | 3 | IPR002129 | |
| Domain | MacrogloblnA2_CS | 2.74e-04 | 8 | 325 | 3 | IPR019742 | |
| Domain | GDA1_CD39_NTPASE | 2.74e-04 | 8 | 325 | 3 | PS01238 | |
| Domain | DDC_GAD_HDC_YDC | 2.74e-04 | 8 | 325 | 3 | PS00392 | |
| Domain | - | 3.02e-04 | 2 | 325 | 2 | 3.40.50.670 | |
| Domain | DTHCT | 3.02e-04 | 2 | 325 | 2 | IPR012542 | |
| Domain | DNA_gyraseB | 3.02e-04 | 2 | 325 | 2 | PF00204 | |
| Domain | - | 3.02e-04 | 2 | 325 | 2 | 3.90.199.10 | |
| Domain | RhoGAP-FF1 | 3.02e-04 | 2 | 325 | 2 | PF16512 | |
| Domain | Topo_IIA_A/C_ab | 3.02e-04 | 2 | 325 | 2 | IPR013758 | |
| Domain | Topo_IIA_A_a | 3.02e-04 | 2 | 325 | 2 | IPR013757 | |
| Domain | Topo_IIA_cen_dom | 3.02e-04 | 2 | 325 | 2 | IPR013759 | |
| Domain | TOP4c | 3.02e-04 | 2 | 325 | 2 | SM00434 | |
| Domain | TOP2c | 3.02e-04 | 2 | 325 | 2 | SM00433 | |
| Domain | Topo_IIA-like_dom | 3.02e-04 | 2 | 325 | 2 | IPR013760 | |
| Domain | TOPRIM_C | 3.02e-04 | 2 | 325 | 2 | IPR031660 | |
| Domain | ATM/Tel1 | 3.02e-04 | 2 | 325 | 2 | IPR015519 | |
| Domain | Topo_IIA_A/C | 3.02e-04 | 2 | 325 | 2 | IPR002205 | |
| Domain | TOPOISOMERASE_II | 3.02e-04 | 2 | 325 | 2 | PS00177 | |
| Domain | RhoGAP-FF1 | 3.02e-04 | 2 | 325 | 2 | IPR032835 | |
| Domain | TopoIIA_CS | 3.02e-04 | 2 | 325 | 2 | IPR018522 | |
| Domain | Topo_IIA | 3.02e-04 | 2 | 325 | 2 | IPR001241 | |
| Domain | DNA_topoisoIV | 3.02e-04 | 2 | 325 | 2 | PF00521 | |
| Domain | Topo_IIA_bsu_dom2 | 3.02e-04 | 2 | 325 | 2 | IPR013506 | |
| Domain | DTHCT | 3.02e-04 | 2 | 325 | 2 | PF08070 | |
| Domain | - | 3.02e-04 | 2 | 325 | 2 | 1.10.268.10 | |
| Domain | TOPRIM_C | 3.02e-04 | 2 | 325 | 2 | PF16898 | |
| Domain | WD_REPEATS_1 | KIF21B EML6 WDR76 HERC1 GNB3 WDR48 CORO2A WDR19 NBAS WDR11 DNAI4 TAF5L EML1 TBL2 | 3.89e-04 | 278 | 325 | 14 | PS00678 |
| Domain | WD_REPEATS_2 | KIF21B EML6 WDR76 HERC1 GNB3 WDR48 CORO2A WDR19 NBAS WDR11 DNAI4 TAF5L EML1 TBL2 | 4.03e-04 | 279 | 325 | 14 | PS50082 |
| Domain | WD_REPEATS_REGION | KIF21B EML6 WDR76 HERC1 GNB3 WDR48 CORO2A WDR19 NBAS WDR11 DNAI4 TAF5L EML1 TBL2 | 4.03e-04 | 279 | 325 | 14 | PS50294 |
| Domain | Calx_beta | 4.06e-04 | 9 | 325 | 3 | IPR003644 | |
| Domain | Calx-beta | 4.06e-04 | 9 | 325 | 3 | PF03160 | |
| Domain | A2M | 5.72e-04 | 10 | 325 | 3 | PF00207 | |
| Domain | A2M_N_2 | 5.72e-04 | 10 | 325 | 3 | IPR011625 | |
| Domain | A2M_comp | 5.72e-04 | 10 | 325 | 3 | IPR011626 | |
| Domain | A2M_recep | 5.72e-04 | 10 | 325 | 3 | PF07677 | |
| Domain | A2M_comp | 5.72e-04 | 10 | 325 | 3 | PF07678 | |
| Domain | A2M_N_2 | 5.72e-04 | 10 | 325 | 3 | PF07703 | |
| Domain | A2M_N | 5.72e-04 | 10 | 325 | 3 | PF01835 | |
| Domain | A2M_N | 5.72e-04 | 10 | 325 | 3 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 5.72e-04 | 10 | 325 | 3 | IPR009048 | |
| Domain | ALPHA_2_MACROGLOBULIN | 5.72e-04 | 10 | 325 | 3 | PS00477 | |
| Domain | Macroglobln_a2 | 5.72e-04 | 10 | 325 | 3 | IPR001599 | |
| Domain | ACTININ_2 | 6.14e-04 | 23 | 325 | 4 | PS00020 | |
| Domain | ACTININ_1 | 6.14e-04 | 23 | 325 | 4 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 6.14e-04 | 23 | 325 | 4 | IPR001589 | |
| Domain | WD40 | KIF21B EML6 WDR76 HERC1 GNB3 WDR48 CORO2A WDR19 WDR11 DNAI4 TAF5L EML1 TBL2 | 6.42e-04 | 259 | 325 | 13 | PF00400 |
| Domain | WD40 | KIF21B EML6 WDR76 HERC1 GNB3 WDR48 CORO2A WDR19 WDR11 DNAI4 TAF5L EML1 TBL2 | 8.81e-04 | 268 | 325 | 13 | SM00320 |
| Domain | - | 8.95e-04 | 3 | 325 | 2 | 3.30.70.590 | |
| Domain | Arg_repress_C-like | 8.95e-04 | 3 | 325 | 2 | IPR024946 | |
| Domain | - | 8.95e-04 | 3 | 325 | 2 | 3.30.1360.40 | |
| Domain | PolA_pol_cen_dom | 8.95e-04 | 3 | 325 | 2 | IPR007012 | |
| Domain | PolA_pol_RNA-bd_dom | 8.95e-04 | 3 | 325 | 2 | IPR007010 | |
| Domain | EST1 | 8.95e-04 | 3 | 325 | 2 | IPR019458 | |
| Domain | NuclTrfase_I_C | 8.95e-04 | 3 | 325 | 2 | IPR011068 | |
| Domain | PAP_central | 8.95e-04 | 3 | 325 | 2 | PF04928 | |
| Domain | PAP_RNA-bind | 8.95e-04 | 3 | 325 | 2 | PF04926 | |
| Domain | EST1 | 8.95e-04 | 3 | 325 | 2 | PF10374 | |
| Pubmed | KNTC1 SMG1 RPL27 ACACB ZNF658 STRBP SPTAN1 SPTBN1 EML6 TOMM20 ZBTB41 SRCAP NEB CEP128 CHUK RUNDC3A NRXN3 SYNE2 CLTC CHD6 TOP3B AP3D1 LCMT1 HNRNPDL FLG KRT1 CNTRL SLC44A2 MAGI3 ST3GAL2 KRT79 INSYN2A SPTBN4 INA SND1 CIAO3 TKT DNAJC11 YLPM1 SUPT16H DNAJC5 MACF1 HADHA PRKDC ATM POTEJ TOP2A TOP2B RPL13 | 1.17e-14 | 1442 | 331 | 49 | 35575683 | |
| Pubmed | MKRN3 USP34 GAD2 DCHS2 SF3B4 ABCF1 TRPM7 SPTAN1 SPTBN1 PEG3 VPS26C DSCAML1 CHUK JAK1 S100B UBA7 ZNF660 CLTC USP7 CHD6 MERTK FN1 CORO2A TTC27 MAGI3 SMG5 GRIN2B AIP TMED4 WDR19 SPTBN4 ARHGAP5 PPP5C CIAO3 SH3D19 YLPM1 LRP2 MACF1 KDM4A PRKDC ATM USP54 PCCB ABHD12 RPL13 | 5.59e-14 | 1285 | 331 | 45 | 35914814 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | KIF21B DCHS2 ABCF1 ACACB SEPTIN9 SPTBN1 NEB DYSF COPS2 MAP3K4 NCBP3 KMT2C USP7 C4A C4B HERC1 TOP3B AP3D1 RIOK1 FN1 POLD1 XIRP2 ASS1 KDM4A ATM TBL2 | 2.99e-12 | 497 | 331 | 26 | 36774506 |
| Pubmed | 1.96e-11 | 8 | 331 | 6 | 1690992 | ||
| Pubmed | 4.00e-11 | 15 | 331 | 7 | 6101098 | ||
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | A2M RPL27 SEPTIN9 SPTAN1 SPTBN1 MCM6 GMPS CLTC C4A C4B GPI SEMG1 FLG CASC3 SRSF4 LCN1 SND1 TKT SUPT16H CD44 HADHA PRKDC RPL13 HDLBP | 4.71e-11 | 477 | 331 | 24 | 31300519 |
| Pubmed | 7.06e-11 | 16 | 331 | 7 | 23123061 | ||
| Pubmed | KIF21B SF3B4 ABCF1 SEPTIN9 SPTAN1 SPTBN1 NCBP3 GLB1 CLTC USP7 HNRNPDL SRSF4 SRSF6 API5 SND1 YLPM1 SUPT16H CD44 CTNNBL1 KIRREL1 MACF1 HADHA PRKDC POTEJ TOP2A TOP2B PHLDB2 | 2.93e-10 | 660 | 331 | 27 | 32780723 | |
| Pubmed | RPL27 PDE3B ABCB7 ABCF1 TRPM7 SPTAN1 SPTBN1 ADA CEMIP2 NCBP3 GLB1 SYNE2 CLTC DNAJC9 TOP3B AP3D1 SRSF6 WFS1 POLD1 SCAMP1 AIP WDR19 NBAS PPP5C SND1 WDR11 DNAJC11 SUPT16H MTR DNAJC5 PLEKHA1 KIRREL1 MACF1 CDK5RAP2 HADHA ATM CRYBG3 ABHD12 TBL2 TOP2B RPL13 HDLBP | 3.61e-10 | 1487 | 331 | 42 | 33957083 | |
| Pubmed | A2M SF3B4 STRBP SEPTIN9 SPTAN1 SPTBN1 PEG3 WDR76 ALKBH5 NCBP3 CLTC DNAJC9 C4B AP3D1 ZNF574 GPI KRT1 CASC3 UBE2NL RIOK1 COL11A1 FN1 WFS1 SMARCAL1 WRN AAK1 AIP AGPS APRT TMED4 ARHGAP5 TKT YLPM1 SUPT16H CTNNBL1 HAGH HADHA POTEJ MUC5AC HDLBP | 3.88e-10 | 1371 | 331 | 40 | 36244648 | |
| Pubmed | USP34 SMG1 RTEL1 SNRK DSCAML1 KMT2C SYNE2 CHD6 SMG6 WDR48 SMG5 ARHGAP35 ADGRA2 DIP2C MACF1 UNC80 | 6.28e-10 | 225 | 331 | 16 | 12168954 | |
| Pubmed | A mouse carcinoembryonic antigen gene family member is a calcium-dependent cell adhesion molecule. | 1.15e-09 | 13 | 331 | 6 | 1985902 | |
| Pubmed | CEACAM1+ myeloid cells control angiogenesis in inflammation. | 1.15e-09 | 13 | 331 | 6 | 19273835 | |
| Pubmed | 1.15e-09 | 13 | 331 | 6 | 20044046 | ||
| Pubmed | 1.15e-09 | 13 | 331 | 6 | 32150576 | ||
| Pubmed | 1.15e-09 | 13 | 331 | 6 | 6265583 | ||
| Pubmed | CEACAM1 is a potent regulator of B cell receptor complex-induced activation. | 1.15e-09 | 13 | 331 | 6 | 12832451 | |
| Pubmed | 1.15e-09 | 13 | 331 | 6 | 25406283 | ||
| Pubmed | 1.15e-09 | 13 | 331 | 6 | 8380065 | ||
| Pubmed | 1.15e-09 | 13 | 331 | 6 | 1279194 | ||
| Pubmed | 1.15e-09 | 13 | 331 | 6 | 25724769 | ||
| Pubmed | 1.15e-09 | 13 | 331 | 6 | 26374765 | ||
| Pubmed | CEACAM1 deficiency delays important wound healing processes. | 1.15e-09 | 13 | 331 | 6 | 22092845 | |
| Pubmed | 1.15e-09 | 13 | 331 | 6 | 28913658 | ||
| Pubmed | Expression of the Bgp gene and characterization of mouse colon biliary glycoprotein isoforms. | 1.15e-09 | 13 | 331 | 6 | 8500759 | |
| Pubmed | Mouse susceptibility to mouse hepatitis virus infection is linked to viral receptor genotype. | 1.15e-09 | 13 | 331 | 6 | 9343248 | |
| Pubmed | Ceacam1 deletion causes vascular alterations in large vessels. | 1.15e-09 | 13 | 331 | 6 | 23800882 | |
| Pubmed | 1.15e-09 | 13 | 331 | 6 | 19285068 | ||
| Pubmed | Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. | 1.15e-09 | 13 | 331 | 6 | 1326665 | |
| Pubmed | Conditional deletion of CEACAM1 in hepatic stellate cells causes their activation. | 1.15e-09 | 13 | 331 | 6 | 39168268 | |
| Pubmed | 1.15e-09 | 13 | 331 | 6 | 8402684 | ||
| Pubmed | 1.15e-09 | 13 | 331 | 6 | 27002145 | ||
| Pubmed | Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitis. | 1.15e-09 | 13 | 331 | 6 | 21949477 | |
| Pubmed | 1.15e-09 | 13 | 331 | 6 | 26219866 | ||
| Pubmed | 1.15e-09 | 13 | 331 | 6 | 2133556 | ||
| Pubmed | 1.15e-09 | 13 | 331 | 6 | 19621080 | ||
| Pubmed | Expression of newly identified secretory CEACAM1(a) isoforms in the intestinal epithelium. | 1.15e-09 | 13 | 331 | 6 | 19358828 | |
| Pubmed | 1.15e-09 | 13 | 331 | 6 | 16680193 | ||
| Pubmed | Regulation of hepatic fibrosis by carcinoembryonic antigen-related cell adhesion molecule 1. | 1.15e-09 | 13 | 331 | 6 | 34058224 | |
| Pubmed | 1.15e-09 | 13 | 331 | 6 | 10964771 | ||
| Pubmed | In vivo adaptation and persistence of Neisseria meningitidis within the nasopharyngeal mucosa. | 1.15e-09 | 13 | 331 | 6 | 23935487 | |
| Pubmed | Forced Hepatic Overexpression of CEACAM1 Curtails Diet-Induced Insulin Resistance. | 1.15e-09 | 13 | 331 | 6 | 25972571 | |
| Pubmed | 1.15e-09 | 13 | 331 | 6 | 18544705 | ||
| Pubmed | Expression of the mouse hepatitis virus receptor by central nervous system microglia. | 1.15e-09 | 13 | 331 | 6 | 15220458 | |
| Pubmed | 1.15e-09 | 13 | 331 | 6 | 18843289 | ||
| Pubmed | 1.15e-09 | 13 | 331 | 6 | 15207636 | ||
| Pubmed | 1.15e-09 | 13 | 331 | 6 | 21081647 | ||
| Pubmed | 1.15e-09 | 13 | 331 | 6 | 11133662 | ||
| Pubmed | 1.15e-09 | 13 | 331 | 6 | 11483763 | ||
| Pubmed | 1.15e-09 | 13 | 331 | 6 | 18003729 | ||
| Pubmed | 1.15e-09 | 13 | 331 | 6 | 20739537 | ||
| Pubmed | The role of CEA-related cell adhesion molecule-1 (CEACAM1) in vascular homeostasis. | 1.15e-09 | 13 | 331 | 6 | 27695943 | |
| Pubmed | 1.15e-09 | 13 | 331 | 6 | 20404914 | ||
| Pubmed | Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1. | 1.15e-09 | 13 | 331 | 6 | 16638824 | |
| Pubmed | 1.15e-09 | 13 | 331 | 6 | 34440862 | ||
| Pubmed | Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor. | 1.15e-09 | 13 | 331 | 6 | 21670291 | |
| Pubmed | 1.15e-09 | 13 | 331 | 6 | 22162753 | ||
| Pubmed | 1.15e-09 | 13 | 331 | 6 | 2702644 | ||
| Pubmed | 1.15e-09 | 13 | 331 | 6 | 11801635 | ||
| Pubmed | 1.15e-09 | 13 | 331 | 6 | 21760897 | ||
| Pubmed | 1.15e-09 | 13 | 331 | 6 | 1719235 | ||
| Pubmed | 1.15e-09 | 13 | 331 | 6 | 16619040 | ||
| Pubmed | 1.15e-09 | 13 | 331 | 6 | 29377208 | ||
| Pubmed | Expression of MHV-A59 receptor glycoproteins in susceptible and resistant strains of mice. | 1.15e-09 | 13 | 331 | 6 | 8209741 | |
| Pubmed | 1.15e-09 | 13 | 331 | 6 | 32521208 | ||
| Pubmed | 1.15e-09 | 13 | 331 | 6 | 19406938 | ||
| Pubmed | CEACAM1 promotes CD8+ T cell responses and improves control of a chronic viral infection. | 1.15e-09 | 13 | 331 | 6 | 29967450 | |
| Pubmed | 1.15e-09 | 13 | 331 | 6 | 1653760 | ||
| Pubmed | 1.15e-09 | 13 | 331 | 6 | 32169849 | ||
| Pubmed | 1.15e-09 | 13 | 331 | 6 | 22469976 | ||
| Pubmed | CEACAM1 creates a pro-angiogenic tumor microenvironment that supports tumor vessel maturation. | 1.15e-09 | 13 | 331 | 6 | 21532628 | |
| Pubmed | Structural and Molecular Evidence Suggesting Coronavirus-driven Evolution of Mouse Receptor. | 1.15e-09 | 13 | 331 | 6 | 28035001 | |
| Pubmed | Interaction between altered insulin and lipid metabolism in CEACAM1-inactive transgenic mice. | 1.15e-09 | 13 | 331 | 6 | 15316023 | |
| Pubmed | 1.15e-09 | 13 | 331 | 6 | 15331748 | ||
| Pubmed | 1.15e-09 | 13 | 331 | 6 | 22673933 | ||
| Pubmed | Tumor angiogenesis mediated by myeloid cells is negatively regulated by CEACAM1. | 1.15e-09 | 13 | 331 | 6 | 22406619 | |
| Pubmed | 1.15e-09 | 13 | 331 | 6 | 7628460 | ||
| Pubmed | 1.15e-09 | 13 | 331 | 6 | 19008452 | ||
| Pubmed | 1.15e-09 | 13 | 331 | 6 | 2164599 | ||
| Pubmed | 1.15e-09 | 13 | 331 | 6 | 29396368 | ||
| Pubmed | 1.15e-09 | 13 | 331 | 6 | 26284027 | ||
| Pubmed | CEACAM1 specifically suppresses B cell receptor signaling-mediated activation. | 1.15e-09 | 13 | 331 | 6 | 33352461 | |
| Pubmed | 1.15e-09 | 13 | 331 | 6 | 38381498 | ||
| Pubmed | 1.15e-09 | 13 | 331 | 6 | 1633107 | ||
| Pubmed | 1.15e-09 | 13 | 331 | 6 | 26911181 | ||
| Pubmed | Hepatic CEACAM1 expression indicates donor liver quality and prevents early transplantation injury. | 1.15e-09 | 13 | 331 | 6 | 32027621 | |
| Pubmed | 1.15e-09 | 13 | 331 | 6 | 30664851 | ||
| Pubmed | Role for hepatic CEACAM1 in regulating fatty acid metabolism along the adipocyte-hepatocyte axis. | 1.15e-09 | 13 | 331 | 6 | 27777319 | |
| Pubmed | 1.15e-09 | 13 | 331 | 6 | 18848945 | ||
| Pubmed | DOCK4 GAD1 RPL27 GAD2 ABCF1 ACACB SEPTIN9 SPTAN1 SPTBN1 SNRK GMPS CLTC USP7 SYT1 ALDH6A1 NOS1 WFS1 SCAMP1 CAPN2 AAK1 LRRC4B ZDBF2 GRIN2B LRRC4C ARHGAP35 INA PPP5C DNAJC11 MACF1 HADHA CRYBG3 PCCB ABHD12 RPL13 HDLBP | 1.41e-09 | 1139 | 331 | 35 | 36417873 | |
| Pubmed | USP34 ABCB7 GALNT1 SPTBN1 PEG3 ZBTB41 ACVR2A SRCAP COPS2 KMT2C PAPOLA NFE2L1 ALDH1L2 CLTC SYT1 LMAN2 HERC1 PLEKHA7 HNRNPDL PANK3 FN1 SCAMP1 CNTRL ST3GAL2 ARHGAP5 CNOT6L DDHD1 ENTPD6 ZBTB10 LRP2 MACF1 CDK5RAP2 HMGXB3 IPMK | 1.46e-09 | 1084 | 331 | 34 | 11544199 | |
| Pubmed | Characterization of cDNA encoding novel pregnancy-specific glycoprotein variants. | 1.57e-09 | 7 | 331 | 5 | 7794280 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | RPL27 SF3B4 ABCF1 SEPTIN9 SPTAN1 SPTBN1 MCM6 COPS2 GMPS CLTC DNAJC9 USP7 AP3D1 HNRNPDL GPI KRT1 RIOK1 SRSF4 CORO2A POLD1 AIP API5 MORC4 APRT INA PPP5C SND1 TKT SUPT16H MACF1 HAGH HADHA PRKDC RPL13 HDLBP | 1.76e-09 | 1149 | 331 | 35 | 35446349 |
| Pubmed | 2.00e-09 | 14 | 331 | 6 | 37531413 | ||
| Pubmed | Human CEACAM1-LF regulates lipid storage in HepG2 cells via fatty acid transporter CD36. | 2.00e-09 | 14 | 331 | 6 | 34666041 | |
| Pubmed | 2.00e-09 | 14 | 331 | 6 | 34619794 | ||
| Pubmed | 2.00e-09 | 14 | 331 | 6 | 8896983 | ||
| Pubmed | 2.00e-09 | 14 | 331 | 6 | 22962327 | ||
| Pubmed | 2.00e-09 | 14 | 331 | 6 | 17623671 | ||
| Pubmed | 2.00e-09 | 14 | 331 | 6 | 26846848 | ||
| Interaction | FBXO22 interactions | KIF21B DCHS2 ABCF1 ACACB SEPTIN9 SPTBN1 NEB DYSF COPS2 MAP3K4 NCBP3 KMT2C USP7 C4A C4B HERC1 TOP3B AP3D1 RIOK1 FN1 POLD1 XIRP2 ASS1 KDM4A ATM TBL2 | 9.83e-07 | 540 | 329 | 26 | int:FBXO22 |
| Interaction | PSG1 interactions | 1.60e-06 | 51 | 329 | 8 | int:PSG1 | |
| Interaction | MYO7B interactions | 4.31e-06 | 3 | 329 | 3 | int:MYO7B | |
| Interaction | DCAF4 interactions | USP34 TBKBP1 ACACB COPS2 CEP128 S100B USP7 CHD6 TOP3B WDR48 HNRNPDL AIP NBAS SUPT16H KIRREL1 USP54 PCCB TOP2A TOP2B PHLDB2 | 4.51e-06 | 378 | 329 | 20 | int:DCAF4 |
| Interaction | PSG11 interactions | 6.43e-06 | 61 | 329 | 8 | int:PSG11 | |
| Interaction | MAGOH interactions | DOCK4 SMG1 SPTAN1 SPTBN1 JAK1 DNAJC9 SMG6 KRT1 CASC3 RIOK1 SRSF4 SRSF6 POLD1 POTEJ TOP2A RPL13 | 7.70e-06 | 264 | 329 | 16 | int:MAGOH |
| Interaction | NUPR1 interactions | KIF21B SF3B4 ABCF1 SEPTIN9 SPTAN1 SPTBN1 NCBP3 GLB1 CLTC USP7 HNRNPDL SEMG1 SRSF4 SRSF6 API5 SND1 YLPM1 SUPT16H CD44 CTNNBL1 KIRREL1 MACF1 HADHA PRKDC POTEJ TOP2A TOP2B PHLDB2 | 8.28e-06 | 683 | 329 | 28 | int:NUPR1 |
| Interaction | KLHL14 interactions | 1.17e-05 | 66 | 329 | 8 | int:KLHL14 | |
| Interaction | WRN interactions | TOP3B WDR48 RAD52 SMARCAL1 WRN SUPT16H CTNNBL1 PRKDC ATM HDLBP | 1.30e-05 | 110 | 329 | 10 | int:WRN |
| Interaction | ATG16L1 interactions | RPL27 TBKBP1 ACACB TOMM20 TUBGCP2 ALKBH5 CLTC DNAJC9 SYT1 KATNIP KAZN HERC1 WDR48 HNRNPDL CORO2A POLD1 SCAMP1 CNTRL CALCOCO1 IKBKG AGPS NBAS SND1 CD22 YLPM1 SUPT16H CTNNBL1 MTR KIRREL1 CDK5RAP2 ATM USP54 CRYBG3 PCCB TBL2 TOP2A TOP2B PHLDB2 HDLBP | 1.57e-05 | 1161 | 329 | 39 | int:ATG16L1 |
| Interaction | GSK3B interactions | UBR1 ACACB SEPTIN9 MCM6 COPS2 MAP3K4 GMPS MAST4 NFATC2 ATXN1 NFE2L1 CLTC USP7 LMAN2 CHD6 GPI CAPN2 IKBKG ZDBF2 ARHGAP35 SPTBN4 INA SND1 ENTPD6 LRP6 MACF1 HADHA PRKDC CRYBG3 MUC5AC TOP2A RPL13 | 1.60e-05 | 868 | 329 | 32 | int:GSK3B |
| Interaction | TNRC6A interactions | TBKBP1 TOMM20 CNOT6 KMT2C STX4 GLDC CLTC ANAPC5 SRSF6 CNTRL IKBKG SMG5 CNOT6L ZBTB10 USP54 HDLBP | 1.60e-05 | 280 | 329 | 16 | int:TNRC6A |
| Interaction | METTL14 interactions | UBR1 RPL27 SF3B4 ABCF1 CHDH SPTAN1 SPTBN1 MCM6 USP7 C4A MAP3K15 HERC1 SMG6 HNRNPDL FLG KRT1 FN1 SRSF6 SND1 PRKDC TOP2A TOP2B RPL13 HDLBP | 1.72e-05 | 558 | 329 | 24 | int:METTL14 |
| Interaction | MEX3A interactions | TBKBP1 MYO10 SPTAN1 SPTBN1 EML6 CNOT6 JAK1 NFE2L1 CLTC CASC3 SRSF4 CORO2A CAPN2 SUPT16H MACF1 HMGXB3 PRKDC TOP2A ALPK2 | 2.00e-05 | 384 | 329 | 19 | int:MEX3A |
| Interaction | KIF20A interactions | CAPN12 SF3B4 ABCF1 TBKBP1 SPTAN1 SPTBN1 EML6 TUBGCP2 DOCK5 GLB1 SYNE2 CLTC HERC1 GNB3 SMG6 HNRNPDL SRSF6 LRRK1 SPTBN4 GNA14 INA YLPM1 SUPT16H CD44 MACF1 CDK5RAP2 HAGH HADHA PRKDC USP54 CRYBG3 POTEJ TOP2A TOP2B PHLDB2 RPL13 | 2.31e-05 | 1052 | 329 | 36 | int:KIF20A |
| Interaction | NLGN3 interactions | 3.52e-05 | 99 | 329 | 9 | int:NLGN3 | |
| Interaction | DHX9 interactions | RPL27 ABCF1 MAN2C1 STRBP SPTAN1 WDR76 ATXN1 GLDC USP7 TOP3B HNRNPDL RIOK1 FN1 SRSF6 NGB POLD1 WRN API5 INA PPP5C SND1 SUPT16H HAGH PRKDC TOP2A HDLBP | 3.63e-05 | 662 | 329 | 26 | int:DHX9 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | CAPN12 PSG2 PSG3 PSG4 PSG5 PSG7 PSG9 PSG11 PEG3 PRODH2 ZIK1 GAPDHS NCR1 ZNF574 GPI LILRB3 ZSCAN5A POLD1 LRRC4B ARHGAP35 SPTBN4 LIPE PPP5C CD22 ZNF749 ZNF470 | 7.22e-07 | 1192 | 331 | 26 | chr19q13 |
| Cytoband | 19q13.2 | 3.36e-06 | 164 | 331 | 9 | 19q13.2 | |
| GeneFamily | CD molecules|V-set domain containing|Pregnancy specific glycoproteins | 1.25e-11 | 11 | 223 | 7 | 1315 | |
| GeneFamily | WD repeat domain containing | KIF21B EML6 WDR76 HERC1 GNB3 WDR48 CORO2A WDR19 WDR11 DNAI4 TAF5L EML1 TBL2 | 2.35e-05 | 262 | 223 | 13 | 362 |
| GeneFamily | Topoisomerases | 3.60e-05 | 6 | 223 | 3 | 1050 | |
| GeneFamily | EF-hand domain containing|Spectrins | 6.25e-05 | 7 | 223 | 3 | 1113 | |
| GeneFamily | Glycosyltransferase family 6|Blood group antigens | 8.62e-05 | 37 | 223 | 5 | 454 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 1.47e-04 | 9 | 223 | 3 | 1234 | |
| GeneFamily | Potassium sodium-activated channel subfamily T | 1.51e-04 | 2 | 223 | 2 | 856 | |
| GeneFamily | C2 domain containing|Calpains | 7.55e-04 | 15 | 223 | 3 | 975 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 8.82e-04 | 161 | 223 | 8 | 593 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 9.56e-04 | 163 | 223 | 8 | 590 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | MYO10 SPTBN1 PLEKHA7 RASA3 SPTBN4 PLEKHA1 PHLDB2 CYTH4 ADAP2 | 1.07e-03 | 206 | 223 | 9 | 682 |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 3.33e-03 | 50 | 223 | 4 | 1293 | |
| Coexpression | MITSIADES_RESPONSE_TO_APLIDIN_DN | SEPTIN9 SPTBN1 TOMM20 WDR76 GMPS ATXN1 PIK3CB CLTC USP7 KAZN AP3D1 GPI SCAMP1 SUPT16H MACF1 PRKDC TOP2A | 2.12e-08 | 250 | 329 | 17 | M11318 |
| Coexpression | OUYANG_PROSTATE_CANCER_MARKERS | 2.29e-07 | 35 | 329 | 7 | MM757 | |
| Coexpression | BYSTROEM_CORRELATED_WITH_IL5_DN | 4.21e-07 | 75 | 329 | 9 | MM605 | |
| Coexpression | MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP | PSG2 PSG3 PSG4 PSG5 PSG9 PSG11 COPS2 CEMIP2 FN1 TNC TNFAIP6 CDH11 HDLBP | 5.64e-07 | 182 | 329 | 13 | MM993 |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN | USP34 MAN2C1 ACACB HLA-DPA1 STRBP SPTBN1 SNRK TUBGCP2 PAPOLA ATXN1 SYNE2 FAM76A C4A HERC1 ANAPC5 CASC3 AAK1 MSANTD2 TMED4 PAPOLG ARHGAP5 GXYLT2 DCLRE1C WDR11 CD44 DNAJC5 FHDC1 USP54 | 1.42e-06 | 807 | 329 | 28 | M16651 |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_PCA3_DN | 1.51e-06 | 87 | 329 | 9 | MM851 | |
| Coexpression | GSE2128_CTRL_VS_MIMETOPE_NEGATIVE_SELECTION_DP_THYMOCYTE_C57BL6_DN | SF3B4 EML6 WDR76 PPM1J CEP128 PANK1 MAP3K4 GPI ABCC1 CAPN2 IKBKG ADGB ARHGAP5 | 1.64e-06 | 200 | 329 | 13 | M6185 |
| Coexpression | GIBBONS_GENETIC_MOUSE_MODEL_LUNG_ADENOCARCINOMA_DOWN_IN_METASTASIS | 2.57e-06 | 32 | 329 | 6 | MM2 | |
| Coexpression | MARTINEZ_TP53_TARGETS_UP | USP34 PSG2 PSG3 PSG4 PSG5 PSG9 PSG11 SPTBN1 PEG3 MCM6 TUBGCP2 JAK1 QSOX1 S100B PAPOLA KLHL13 IL33 ZNF574 WDR48 ST3GAL2 ITIH5 LIPE CD44 TNFAIP6 HDLBP | 2.76e-06 | 694 | 329 | 25 | MM1039 |
| Coexpression | LAKE_ADULT_KIDNEY_C6_PROXIMAL_TUBULE_EPITHELIAL_CELLS_FIBRINOGEN_POS_S3 | RPL27 MAST4 SYNE2 ALDH6A1 ARHGAP5 TKT LRP2 PLEKHA1 MACF1 ATM CDH6 PHLDB2 | 3.36e-06 | 181 | 329 | 12 | M39225 |
| Coexpression | GSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_DN | USP34 SMG1 PDE3B SPTBN1 USP7 ZNF479 HERC1 MERTK KRT1 ABCC1 MACF1 ATM | 5.24e-06 | 189 | 329 | 12 | M3112 |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_DN | A2M SF3B4 GALNT1 PSG2 PSG3 PSG4 PSG5 PSG9 PSG11 PAPOLA ANAPC5 | 5.72e-06 | 159 | 329 | 11 | MM760 |
| Coexpression | GSE16385_ROSIGLITAZONE_IL4_VS_IFNG_TNF_STIM_MACROPHAGE_DN | ACACB PSG7 TRPM3 GLDC ASB9 NCR1 TOP3B RHAG GNA14 WDR11 DNAI4 CDH11 | 8.00e-06 | 197 | 329 | 12 | M8025 |
| Coexpression | GSE42088_UNINF_VS_LEISHMANIA_INF_DC_8H_DN | PSG5 NEB ASB9 SYT1 AMMECR1 IL33 FN1 NBAS YLPM1 KDM4A CRYBG3 CDH6 | 8.00e-06 | 197 | 329 | 12 | M9910 |
| Coexpression | GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_LPS_AND_IL10_STIM_MACROPHAGE_DN | MCM6 CEMIP2 PAPOLA CLTC CNTRL MAGI3 LRRK1 ITIH5 ENTPD1 LRP6 TOP2A | 8.15e-06 | 165 | 329 | 11 | M8121 |
| Coexpression | MARTINEZ_RB1_TARGETS_UP | USP34 PSG2 PSG3 PSG4 PSG5 STRBP PSG9 PSG11 SPTBN1 PEG3 MCM6 TUBGCP2 JAK1 QSOX1 PAPOLA ZNF574 WDR48 WRN ST3GAL2 KRT79 ITIH5 LIPE CD44 ATM HDLBP | 8.58e-06 | 741 | 329 | 25 | MM1037 |
| Coexpression | JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN | 1.01e-05 | 60 | 329 | 7 | M1515 | |
| Coexpression | ENK_UV_RESPONSE_KERATINOCYTE_DN | MYO10 VPS26C TOMM20 MCM6 TUBGCP2 COPS2 CLTC USP7 HNRNPDL TNC AGPS ENTPD4 ENTPD6 CD44 MACF1 PRKDC TBL2 TOP2A TOP2B | 1.25e-05 | 481 | 329 | 19 | M3898 |
| Coexpression | ONKEN_UVEAL_MELANOMA_DN | TOMM20 SNRK GMPS GLB1 NFE2L1 GAPDHS ANAPC5 ALDH6A1 PMM1 HNRNPDL SCAMP1 AIP TKT ENTPD1 ENTPD6 YLPM1 CD44 HADHA TOP2B RPL13 | 1.56e-05 | 533 | 329 | 20 | M2605 |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_4_5WK_UP | PSG2 PSG3 PSG4 PSG5 PSG9 PSG11 CEMIP2 IL33 FN1 TNC SLC44A2 FHDC1 TNFAIP6 CDH11 | 1.61e-05 | 284 | 329 | 14 | MM987 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | KIF21B KNTC1 SMG1 MYO10 CHDH KMT2C HERC1 WRN CNOT6L MACF1 ATM | 1.85e-05 | 180 | 329 | 11 | M8239 |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_UP | USP34 PSG2 PSG3 PSG4 PSG5 PSG9 PSG11 SPTBN1 MCM6 TUBGCP2 JAK1 QSOX1 S100B PAPOLA KLHL13 IL33 WDR48 ST3GAL2 ITIH5 LIPE CD44 TNFAIP6 HDLBP | 2.33e-05 | 689 | 329 | 23 | MM1041 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HENDO | A2M SPTBN1 SNRK DYSF CEMIP2 JAK1 SERPINB8 MAST4 PIK3CB ASB9 SEL1L3 EPHX4 CHST7 FN1 WFS1 ICAM2 FRMD8 APRT ADGRA2 MFSD2A GNA14 XIRP2 ENTPD1 PLEKHA1 USP54 CDH11 LRRC36 | 2.38e-05 | 888 | 329 | 27 | M39049 |
| Coexpression | WANG_RESPONSE_TO_BEXAROTENE_UP | 2.94e-05 | 48 | 329 | 6 | MM531 | |
| Coexpression | BUSSLINGER_DUODENAL_STEM_CELLS | RPL27 MYO10 CHDH CEMIP2 PAPOLA SYNE2 HNRNPDL SRSF6 TKT SH3D19 CD44 PRKDC TOP2B RPL13 | 4.37e-05 | 311 | 329 | 14 | M40024 |
| Coexpression | KOBAYASHI_EGFR_SIGNALING_24HR_UP | 4.46e-05 | 102 | 329 | 8 | M10290 | |
| Coexpression | GSE11924_TFH_VS_TH17_CD4_TCELL_UP | UBR1 STX4 KATNIP HERC1 ALDH6A1 SPSB3 SMG6 CNTRL ARHGAP5 FHDC1 ABHD12 | 4.66e-05 | 199 | 329 | 11 | M3156 |
| Coexpression | CHICAS_RB1_TARGETS_LOW_SERUM | 4.78e-05 | 103 | 329 | 8 | M2126 | |
| Coexpression | GSE21063_3H_VS_16H_ANTI_IGM_STIM_BCELL_UP | EPOR NEB MERTK AMMECR1 ALDH6A1 RAD52 ABCC1 MSANTD2 DDHD1 EML1 LY75 | 4.88e-05 | 200 | 329 | 11 | M8264 |
| Coexpression | GSE26030_TH1_VS_TH17_RESTIMULATED_DAY5_POST_POLARIZATION_DN | GALNT1 ZNF658 SEPTIN9 MAP3K4 GLB1 USP42 ANAPC5 SH3D19 HMGXB3 ABHD12 CDH6 | 4.88e-05 | 200 | 329 | 11 | M8574 |
| Coexpression | GSE18281_SUBCAPSULAR_VS_PERIMEDULLARY_CORTICAL_REGION_OF_THYMUS_UP | GALNT1 PANK1 MERTK SPSB3 GPI CASC3 SCAMP1 CIAO3 CRYBG3 ABHD12 TOP2B | 4.88e-05 | 200 | 329 | 11 | M7235 |
| Coexpression | GSE37301_LYMPHOID_PRIMED_MPP_VS_COMMON_LYMPHOID_PROGENITOR_UP | ATXN1 ACSF3 MERTK PLEKHA7 CAPN2 CNOT6L PPP5C CD22 SH3D19 ASS1 MTR | 4.88e-05 | 200 | 329 | 11 | M8853 |
| Coexpression | BROWN_MYELOID_CELL_DEVELOPMENT_UP | 5.10e-05 | 201 | 329 | 11 | MM1006 | |
| Coexpression | JI_RESPONSE_TO_FSH_DN | 5.22e-05 | 53 | 329 | 6 | M17537 | |
| Coexpression | ZHONG_PFC_MAJOR_TYPES_INTERNEURON | 6.49e-05 | 18 | 329 | 4 | M39076 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | DOCK4 KIF21B GAD1 GAD2 PEG3 PDZD7 ACVR2A NEB DSCAML1 FSIP2 RUNDC3A NRXN3 MAST4 NALCN KLHL13 SYT1 HERC1 SARDH COL11A1 ADAMTS3 MAGI3 LRRC4B ARHGAP35 GRM3 INSYN2A CNOT6L INA DCLK3 PLEKHA1 PNCK | 6.92e-05 | 1106 | 329 | 30 | M39071 |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN | PDXDC1 KIF21B SF3B4 MAN2C1 SEPTIN9 SPTAN1 AKR1D1 DYSF CD300C JAK1 UBA7 STX4 KATNIP TOP3B AP3D1 SPSB3 LILRB3 SRSF4 AAK1 IKBKG SMG5 ENTPD4 ITIH5 TAF6L ENTPD6 CYTH4 | 8.56e-05 | 905 | 329 | 26 | M40865 |
| Coexpression | ZWANG_EGF_INTERVAL_UP | 8.68e-05 | 112 | 329 | 8 | M2619 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 | ADAMTS19 GAD1 GAD2 MYO10 PPM1J DYSF ADA DOCK5 FREM2 NFATC2 TRPM3 GLDC HRH1 CHST7 FN1 LRRK1 GXYLT2 NTN4 MFSD2A GNA14 INA GUCY2D ASS1 LRP2 FHDC1 LY75 TOP2A PHLDB2 ADAP2 | 9.91e-05 | 1074 | 329 | 29 | M1941 |
| Coexpression | BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP | A2M ATP8B4 ACACB HLA-DPA1 MYO10 SPTBN1 PEG3 PGM3 SEL1L3 IL33 COL11A1 FN1 CD44 ZBTB10 TNFAIP6 TOP2A | 1.12e-04 | 427 | 329 | 16 | M17923 |
| Coexpression | GSE22611_NOD2_TRANSDUCED_VS_CTRL_HEK293T_STIMULATED_WITH_MDP_2H_DN | KNTC1 ALKBH5 SYNE2 ABCC1 PPP5C SND1 ENTPD6 KIRREL1 TAF5L HDLBP | 1.13e-04 | 183 | 329 | 10 | M8178 |
| Coexpression | GSE38696_LIGHT_ZONE_VS_DARK_ZONE_BCELL_UP | KIF21B ATP8B4 GALNT1 RIOK1 RASA3 IKBKG FRMD8 CNOT6L MACF1 ATM | 1.18e-04 | 184 | 329 | 10 | M9005 |
| Coexpression | ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN | MKRN3 DCHS2 PSG4 MYO10 PEG3 KMT2C ZNF660 HRH1 KAZN GAPDHS FLG SRSF6 PCDHA11 MAGI3 LRRK1 LRRC4C LCN1 ITIH5 PASD1 ADGB SND1 DCLK3 KIRREL1 HMGXB3 BBS12 | 1.23e-04 | 873 | 329 | 25 | M16009 |
| Coexpression | ZHANG_UTERUS_C1_REGENERATIVE_UP | PDXDC1 PSG2 PSG3 PSG4 PSG5 PSG9 PSG11 SPTAN1 COPS2 QSOX1 CAPN2 TMED4 TNFAIP6 | 1.27e-04 | 302 | 329 | 13 | MM16604 |
| Coexpression | RIZKI_TUMOR_INVASIVENESS_3D_DN | SMG1 PSG2 EVX1 CEMIP2 CHUK UBA7 NRXN3 HERC1 GRM3 INA TKT HDLBP | 1.30e-04 | 262 | 329 | 12 | M11472 |
| Coexpression | DESCARTES_FETAL_ADRENAL_CSH1_CSH2_POSITIVE_CELLS | 1.34e-04 | 224 | 329 | 11 | M40145 | |
| Coexpression | MARTINEZ_TP53_TARGETS_UP | USP34 SPTBN1 PEG3 MCM6 TUBGCP2 JAK1 QSOX1 S100B PAPOLA KLHL13 IL33 ZNF574 WDR48 LILRB3 ST3GAL2 ITIH5 LIPE CD44 TNFAIP6 HDLBP | 1.37e-04 | 624 | 329 | 20 | M4371 |
| Coexpression | RIGGI_EWING_SARCOMA_PROGENITOR_UP | A2M ACACB MYO10 PEG3 FREM1 JAK1 KLHL13 SEL1L3 NOS1 COL11A1 ADAMTS3 TNC ICAM2 LRRC4C GNA14 CDH11 | 1.46e-04 | 437 | 329 | 16 | M15981 |
| Coexpression | NAKAMURA_LUNG_CANCER | 1.56e-04 | 9 | 329 | 3 | M6362 | |
| Coexpression | MURARO_PANCREAS_DUCTAL_CELL | A2M HDHD3 ABCF1 GALNT1 PSG4 HLA-DPA1 MYO10 SPTAN1 SPTBN1 RETSAT CEMIP2 QSOX1 GLB1 SYNE2 SEL1L3 LMAN2 CAPN2 SLC44A2 MAGI3 FRMD8 ITIH5 NTN4 SH3D19 ASS1 CD44 MACF1 CD151 HADHA MST1L CDH6 TOP2B PHLDB2 | 1.68e-04 | 1276 | 329 | 32 | M39173 |
| Coexpression | KAUFFMANN_DNA_REPAIR_GENES | TOP3B RAD52 POLD1 WRN DCLRE1C SUPT16H PRKDC ATM TOP2A TOP2B TP73 | 1.69e-04 | 230 | 329 | 11 | M11563 |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_3_4WK_UP | 1.69e-04 | 230 | 329 | 11 | MM986 | |
| Coexpression | DESCARTES_FETAL_PLACENTA_TROPHOBLAST_GIANT_CELLS | 1.73e-04 | 93 | 329 | 7 | M40279 | |
| Coexpression | PUJANA_ATM_PCC_NETWORK | KIF21B KNTC1 USP34 RPL27 ABCB7 SF3B4 HLA-DPA1 MCM6 CD300C CHUK PAPOLA FAM76A DNAJC9 AMMECR1 GNB3 CHST7 ABCC1 SRSF6 RASA3 CNTRL IKBKG PCDHA12 ST3GAL2 ARHGAP35 SLC25A16 CD22 TKT KDM4A PRKDC ATM TAF5L LY75 TOP2A TOP2B | 1.76e-04 | 1394 | 329 | 34 | M9585 |
| Coexpression | ONKEN_UVEAL_MELANOMA_UP | DOCK4 ACACB HLA-DPA1 SPTAN1 SPTBN1 ZNF623 ASB9 SYNE2 SEL1L3 C4A HNRNPDL ABCC1 CAPN2 ASS1 SUPT16H ZBTB10 MTR MACF1 SLC45A2 HMGXB3 PRKDC ATM TBL2 | 1.81e-04 | 790 | 329 | 23 | M12490 |
| Coexpression | MIKKELSEN_NPC_ICP_WITH_H3K4ME3 | A2M TBKBP1 PANK1 ABCA9 S100B ZIK1 SYT1 SPSB3 SMARCAL1 LRRC4B LRRC4C GRM3 DCLRE1C ENTPD1 CD44 TNFAIP6 | 1.98e-04 | 449 | 329 | 16 | M2013 |
| Coexpression | GSE3982_NKCELL_VS_TH2_UP | PDXDC1 GAD2 TBKBP1 PSG3 HLA-DPA1 S100B PRODH2 SYNE2 CALCOCO1 CD44 | 2.06e-04 | 197 | 329 | 10 | M5596 |
| Coexpression | GSE21033_1H_VS_24H_POLYIC_STIM_DC_UP | 2.09e-04 | 161 | 329 | 9 | M7728 | |
| Coexpression | ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_DN | USP34 PDE3B SPTAN1 SPTBN1 ACVR2A CEP128 ZIK1 NFATC2 PARP16 SEL1L3 NCR1 HERC1 HEATR5B RASA3 AAK1 ZDBF2 TLR10 ARHGAP5 CNOT6L CD22 CD44 PLEKHA1 MACF1 PRKDC ATM TOP2B RPL13 | 2.09e-04 | 1012 | 329 | 27 | M40864 |
| Coexpression | CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70 | 2.13e-04 | 68 | 329 | 6 | M305 | |
| Coexpression | GSE22886_NAIVE_CD4_TCELL_VS_DC_UP | RPL27 SPTBN1 TOMM20 SNRK WDR76 UBA7 SYNE2 HERC1 BTN3A2 WDR19 | 2.15e-04 | 198 | 329 | 10 | M4501 |
| Coexpression | CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN | CHDH NCBP3 FREM2 NRXN3 SEL1L3 HRH1 KAZN PLEKHA7 SPSB3 WDR48 KCNT2 SH3D19 DNAI4 FHDC1 BBS12 | 2.18e-04 | 407 | 329 | 15 | M2214 |
| Coexpression | ABRAMSON_INTERACT_WITH_AIRE | 2.20e-04 | 44 | 329 | 5 | M2536 | |
| Coexpression | GSE26156_DOUBLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_UP | 2.23e-04 | 199 | 329 | 10 | M8298 | |
| Coexpression | GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_AND_A3R_INH_PRETREAT_IN_MAST_CELL_DN | CHDH SPTAN1 MAP3K4 FREM2 ANAPC5 ABCC1 SLC44A2 INSYN2A SH3D19 HMGXB3 | 2.23e-04 | 199 | 329 | 10 | M7319 |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | DOCK4 KNTC1 SEPTIN9 SPTAN1 SPTBN1 TUBGCP2 CNTRL ARHGAP5 CDK5RAP2 TOP2A | 2.23e-04 | 199 | 329 | 10 | M5893 |
| Coexpression | GSE3982_MAST_CELL_VS_MAC_UP | KIF21B ATP8B4 NCBP3 JAK1 MAST4 HERC1 HNRNPDL ADAMTS3 ASS1 PRKDC | 2.23e-04 | 199 | 329 | 10 | M5429 |
| Coexpression | GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_2H_UP | RPL27 SPTAN1 JAK1 UBA7 SYNE2 KATNIP ANAPC5 ALDH6A1 CALCOCO1 PRKDC | 2.33e-04 | 200 | 329 | 10 | M6090 |
| Coexpression | GSE3039_NKT_CELL_VS_ALPHABETA_CD8_TCELL_DN | 2.33e-04 | 200 | 329 | 10 | M6430 | |
| Coexpression | GSE19401_PAM2CSK4_VS_RETINOIC_ACID_AND_PAM2CSK4_STIM_FOLLICULAR_DC_DN | PDE3B MAN2C1 SEPTIN9 UBA7 HNRNPDL FN1 CAPN2 ENTPD1 CD151 ATM | 2.33e-04 | 200 | 329 | 10 | M7668 |
| Coexpression | GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP | DOCK4 TRPM7 SPTAN1 PANK1 HEATR5B ABCC1 CALCOCO1 IKBKG APRT ADGB | 2.33e-04 | 200 | 329 | 10 | M6613 |
| Coexpression | GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_IL6_KO_MACROPHAGE_45MIN_DN | 2.33e-04 | 200 | 329 | 10 | M6626 | |
| Coexpression | GSE34006_A2AR_KO_VS_A2AR_AGONIST_TREATED_TREG_DN | 2.33e-04 | 200 | 329 | 10 | M9049 | |
| Coexpression | GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_BCELL_DN | 2.33e-04 | 200 | 329 | 10 | M6745 | |
| Coexpression | GSE40068_CXCR5NEG_BCL6NEG_CD4_TCELL_VS_CXCR5POS_BCL6NEG_TFH_DN | ATP8B4 CEMIP2 DOCK5 PARP16 CORO2A CAPN2 APRT ENTPD1 CD44 TBL2 | 2.33e-04 | 200 | 329 | 10 | M9263 |
| Coexpression | GSE7460_CD8_TCELL_VS_CD4_TCELL_ACT_DN | 2.33e-04 | 200 | 329 | 10 | M5689 | |
| Coexpression | IRITANI_MAD1_TARGETS_DN | 2.45e-04 | 45 | 329 | 5 | MM1263 | |
| Coexpression | KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_UP | DOCK4 KIF21B GAD1 RPL27 SPTAN1 NDUFA1 S100B RUNDC3A STX4 LMAN2L NFE2L1 ANAPC5 PMM1 GPI INA TKT DNAJC11 ENTPD6 ASS1 HAGH HADHA RPL13 | 2.47e-04 | 755 | 329 | 22 | M2105 |
| Coexpression | IRITANI_MAD1_TARGETS_DN | 2.72e-04 | 46 | 329 | 5 | M1944 | |
| Coexpression | LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM | ACACB PRODH2 TRPM3 NFE2L1 CLTC CHD6 PLEKHA7 ALDH6A1 AP3D1 SMG6 GRIN2B LRRC4C WDR19 ASS1 LRP2 | 2.82e-04 | 417 | 329 | 15 | M39224 |
| Coexpression | KALMA_E2F1_TARGETS | 3.00e-04 | 11 | 329 | 3 | M10142 | |
| Coexpression | MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN | ABCB7 ABCF1 TBKBP1 GALNT1 PAPOLA ANAPC5 ZNF574 PANK3 TNC CNTRL AGPS RHAG ARHGAP5 CNOT6L SH3D19 SUPT16H HDLBP | 3.37e-04 | 519 | 329 | 17 | M3395 |
| Coexpression | TABULA_MURIS_SENIS_SUBCUTANEOUS_ADIPOSE_TISSUE_EPITHELIAL_CELL_AGEING | HDHD3 PSG2 PSG3 PSG4 PSG5 MYO10 PSG9 PSG11 SPTBN1 CEMIP2 NCBP3 SECTM1 CALCOCO1 SLC44A2 ARHGAP35 LIPE SND1 CD44 | 3.37e-04 | 568 | 329 | 18 | MM3824 |
| Coexpression | PUJANA_BRCA2_PCC_NETWORK | KNTC1 ABCB7 MCM6 ADA GMPS DNAJC9 ABCC1 POLD1 CNTRL WRN AGPS DNAJC5 PRKDC PCCB TOP2A | 3.54e-04 | 426 | 329 | 15 | M9516 |
| Coexpression | ZHENG_RESPONSE_TO_ARSENITE_DN | 3.96e-04 | 12 | 329 | 3 | M1525 | |
| Coexpression | SABATES_COLORECTAL_ADENOMA_UP | 4.03e-04 | 140 | 329 | 8 | M929 | |
| Coexpression | JOHNSTONE_PARVB_TARGETS_3_UP | HLA-DPA1 SEPTIN9 SPTBN1 RETSAT JAK1 GLB1 NFE2L1 SARDH ANAPC5 FN1 MORC4 ARHGAP5 TKT ATM ABHD12 | 4.19e-04 | 433 | 329 | 15 | M2240 |
| Coexpression | BROWNE_HCMV_INFECTION_48HR_DN | ACACB PSG3 PSG4 PSG11 UBA7 NCR1 ALDH6A1 RAD52 COL11A1 FN1 APRT BTN3A2 MTR CD151 ZNF749 CDH6 | 4.34e-04 | 482 | 329 | 16 | M12144 |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_DN | 4.49e-04 | 78 | 329 | 6 | M9814 | |
| Coexpression | SWEET_LUNG_CANCER_KRAS_UP | PSG2 PSG3 PSG4 PSG5 PSG9 PSG11 PAPOLA SPSB3 GPI SRSF6 SCAMP1 SND1 ENTPD1 CD44 LRP2 LY75 HDLBP | 4.66e-04 | 534 | 329 | 17 | MM1050 |
| Coexpression | MARTINEZ_RB1_TARGETS_UP | USP34 STRBP SPTBN1 PEG3 MCM6 TUBGCP2 JAK1 QSOX1 PAPOLA ZNF574 WDR48 LILRB3 WRN ST3GAL2 KRT79 ITIH5 LIPE CD44 ATM HDLBP | 5.02e-04 | 690 | 329 | 20 | M12224 |
| Coexpression | MEBARKI_HCC_PROGENITOR_FZD8CRD_UP | KNTC1 GAD1 PSG2 PSG3 PSG5 PSG9 WDR76 CEP128 NRXN3 DNAJC9 HNRNPDL SLC44A2 NTN4 FHDC1 TAF5L TOP2A CYTH4 TP73 | 5.07e-04 | 588 | 329 | 18 | M38992 |
| Coexpression | STARK_HYPPOCAMPUS_22Q11_DELETION_UP | 5.29e-04 | 53 | 329 | 5 | MM582 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | A2M MYO7B NEB DSCAML1 FREM1 FREM2 TRPM3 UNC5D COL11A1 MUC5B GRIN2B LRRC4C XIRP2 LRP2 UNC80 | 9.51e-12 | 184 | 331 | 15 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | A2M MYO7B NEB DSCAML1 FREM1 FREM2 TRPM3 UNC5D COL11A1 MUC5B GRIN2B LRRC4C XIRP2 LRP2 UNC80 | 9.51e-12 | 184 | 331 | 15 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | A2M MYO7B NEB DSCAML1 FREM1 FREM2 TRPM3 UNC5D COL11A1 MUC5B GRIN2B LRRC4C XIRP2 LRP2 UNC80 | 9.51e-12 | 184 | 331 | 15 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | COVID-19-kidney-PCT-S2|kidney / Disease (COVID-19 only), tissue and cell type | CAPN12 MYO7B CHDH DSCAML1 MAST4 TRPM3 SYNE2 SEL1L3 HRH1 UNC5D KCNT2 LRP2 CDH6 ALPK2 | 1.69e-10 | 189 | 331 | 14 | 0be5c669b6b308bd98ddb70c84877c62a6244bbd |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | PDXDC1 SMG1 PDE3B CEMIP2 KMT2C SYNE2 HERC1 SMG6 ABCC1 AAK1 CNOT6L MACF1 ATM | 1.77e-10 | 156 | 331 | 13 | 1545169694f686d28648a68b552c2ae606599d66 |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | PDE3B DSCAML1 NALCN NFATC2 KLHL13 SRSF4 RASA3 TNC KCNT2 SH3D19 CD44 MACF1 CDH6 | 1.37e-09 | 184 | 331 | 13 | d2bf0135eb56bb410997dccea39c5ede88a0617f |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | USP34 SMG1 PDE3B SPTBN1 ACVR2A ATXN1 SYNE2 AAK1 CNOT6L DDHD1 MACF1 ATM | 3.46e-09 | 162 | 331 | 12 | b4535bcb3f469bc139e73f1122f4070013e5a1de |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | CAPN12 MYO7B CHDH PRODH2 MAST4 TRPM3 SYNE2 UNC5D ASS1 LRP2 CDH6 ALPK2 | 1.21e-08 | 181 | 331 | 12 | 9542c19edc9bd2cba68c01c2a8407705398e3011 |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | CAPN12 MYO7B CHDH PRODH2 MAST4 TRPM3 SYNE2 UNC5D ASS1 LRP2 CDH6 ALPK2 | 1.21e-08 | 181 | 331 | 12 | 8f04f8cac5d705dc5f6cf6f4516d6e45b0aa4ae5 |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | USP34 SMG1 PDE3B SPTAN1 ATXN1 SYNE2 HERC1 AAK1 DDHD1 MACF1 ATM EML1 | 1.21e-08 | 181 | 331 | 12 | f2315414e714ac86211546a935660c4be6e85f1b |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | ACACB MYO10 SEPTIN9 FREM1 FREM2 TRPM3 MAP3K15 KAZN MFSD2A LRP2 DIP2C | 1.86e-08 | 151 | 331 | 11 | f4f7156b2c0cfc78fd1841e07c9915d97ced561f |
| ToppCell | facs-Bladder-nan-3m-Epithelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | PDXDC1 GALNT1 SPTAN1 SPTBN1 NDUFA1 ALKBH5 CLTC COL11A1 SND1 SH3D19 MACF1 TOP2B | 2.93e-08 | 196 | 331 | 12 | c0e90d964baa2eb4fbd18a52379ccec5d3bf59a8 |
| ToppCell | facs-Bladder-nan-3m|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | PDXDC1 GALNT1 SPTAN1 SPTBN1 NDUFA1 ALKBH5 CLTC COL11A1 SND1 SH3D19 MACF1 TOP2B | 2.93e-08 | 196 | 331 | 12 | 44f5b1b474399c9316729155f2ea95a82ca66e30 |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ADAMTS19 MYO7B ADCY2 DSCAML1 FREM1 COL11A1 MUC5B GRIN2B KCNT2 LRP2 UNC80 | 3.39e-08 | 160 | 331 | 11 | c381ec6be8cf887861cc18f831a20db42f953fe1 |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ADAMTS19 MYO7B ADCY2 DSCAML1 FREM1 COL11A1 MUC5B GRIN2B KCNT2 LRP2 UNC80 | 3.39e-08 | 160 | 331 | 11 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-1m-Neuronal-Interneuron|1m / Sample Type, Dataset, Time_group, and Cell type. | KIF21B GAD1 GAD2 DCHS2 SPTAN1 DYSF RUNDC3A NRXN3 LCN15 GNB3 INA LRRC36 | 3.67e-08 | 200 | 331 | 12 | fc839e9c33ea1d4ee0f42f21fd32a54e7cbe1f5a |
| ToppCell | droplet-Heart-4Chambers-21m-Hematologic-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CAPN12 SMG1 ATP8B4 FGFRL1 TRPM3 TOP3B FDXACB1 SMG6 AAK1 SLC25A16 ENTPD6 | 6.71e-08 | 171 | 331 | 11 | e852d0e8589eecf4a2e5fea039b52a67c5d58dbd |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | TRPM7 PEG3 ABCA9 ARHGAP5 KCNT2 XIRP2 SUPT16H MACF1 HADHA TOP2B HDLBP | 9.01e-08 | 176 | 331 | 11 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e |
| ToppCell | COVID-19-kidney-Epi_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | DCHS2 DSCAML1 SYNE2 HRH1 KAZN ADAMTS3 KCNT2 LRP2 KIRREL1 CDH6 ALPK2 | 1.01e-07 | 178 | 331 | 11 | 544379f5a6145429762258d426b876bb36c112f5 |
| ToppCell | human_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | MYO10 CEMIP2 NRXN3 TRPM3 KAZN ABCC1 GRIN2B LRRC4C XIRP2 ENTPD1 CRYBG3 | 1.07e-07 | 179 | 331 | 11 | 14fc8ccb6b215063d747643f47d780d2b237eb67 |
| ToppCell | COVID-19-kidney-tDL|COVID-19 / Disease (COVID-19 only), tissue and cell type | CAPN12 MYO7B CHDH DSCAML1 TRPM3 GLDC KLHL13 UNC5D LRP2 PLEKHA1 CDH6 | 1.13e-07 | 180 | 331 | 11 | 864c895b5eaedefae86f5829fa344f7b686fb59f |
| ToppCell | COVID-19-kidney-tDL|kidney / Disease (COVID-19 only), tissue and cell type | CAPN12 MYO7B CHDH MAST4 TRPM3 SEL1L3 UNC5D LRP2 PLEKHA1 CDH6 ALPK2 | 1.66e-07 | 187 | 331 | 11 | d35d27ca3c0e65f92f4508e1cb98a743f44fdcdf |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | CAPN12 MYO7B CHDH PRODH2 MAST4 TRPM3 SYNE2 ASS1 LRP2 CDH6 ALPK2 | 1.66e-07 | 187 | 331 | 11 | dcf6475ece5b34d9d58a0d1f51c18acedb19c119 |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | CAPN12 MYO7B CHDH PRODH2 MAST4 TRPM3 SYNE2 ASS1 LRP2 CDH6 ALPK2 | 1.66e-07 | 187 | 331 | 11 | f1356273bd3587b6883295edf15cb9cdb706c057 |
| ToppCell | COVID-19-kidney-Mito-rich_PCT|kidney / Disease (COVID-19 only), tissue and cell type | MYO7B CHDH DSCAML1 PRODH2 MAST4 TRPM3 SYNE2 ASS1 LRP2 CDH6 ALPK2 | 1.66e-07 | 187 | 331 | 11 | 738ec2611b4be6a08eedad16b57fba84e1f11fef |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | CAPN12 MYO7B CHDH PRODH2 MAST4 TRPM3 PLEKHA7 ASS1 LRP2 CDH6 ALPK2 | 1.76e-07 | 188 | 331 | 11 | f3edcefeef2ce19086032d98b243c02a6d542b38 |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | USP34 SMG1 PDE3B TRPM7 CEMIP2 KMT2C SYNE2 HERC1 SMG6 DDHD1 MACF1 | 1.76e-07 | 188 | 331 | 11 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | CAPN12 MYO7B CHDH PRODH2 MAST4 TRPM3 PLEKHA7 ASS1 LRP2 CDH6 ALPK2 | 1.76e-07 | 188 | 331 | 11 | 0792432cd4c564dea1102241ea9884f7ced7658c |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | CAPN12 MYO7B CHDH PRODH2 MAST4 TRPM3 UNC5D ASS1 LRP2 CDH6 ALPK2 | 1.85e-07 | 189 | 331 | 11 | 204ab61ae606b2d9be0cb6bf6a83a011740693a8 |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | CAPN12 MYO7B CHDH PRODH2 MAST4 TRPM3 UNC5D ASS1 LRP2 CDH6 ALPK2 | 1.85e-07 | 189 | 331 | 11 | 13fd07cc408a9486f61a7b2c3a132c52d14b438d |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | PDE3B SPTBN1 ATXN1 SYNE2 ABCC1 RASA3 AAK1 ARHGAP5 CNOT6L MTR ATM | 2.41e-07 | 194 | 331 | 11 | a44be2f021cfdd0fcdc698c3f04d66db7a1aa6c2 |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | ADAMTS19 SPTBN1 ADCY2 ABCA9 FREM1 MAST4 KAZN FN1 GXYLT2 GNA14 SH3D19 | 2.54e-07 | 195 | 331 | 11 | 70387a62f121f8c374dba1aca9ab65cfed6a0b10 |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | A2M DOCK4 PDE3B MYO10 SPTBN1 QSOX1 KAZN FN1 ITIH5 MACF1 CDH11 | 2.67e-07 | 196 | 331 | 11 | 6730743cf088c419ccc2d28765769fc09d3ba6a7 |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | A2M DOCK4 PDE3B MYO10 SPTBN1 QSOX1 KAZN FN1 ITIH5 MACF1 CDH11 | 2.67e-07 | 196 | 331 | 11 | 21dab89f3699037138a9c7a0e4dc98739a9fad9c |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | USP34 SMG1 PDE3B MAP3K4 KMT2C SYNE2 HERC1 AAK1 ZDBF2 MACF1 ATM | 2.81e-07 | 197 | 331 | 11 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-B-Plasmablast|COVID-19_Severe / Disease, condition lineage and cell class | CEP128 PGM3 GLDC ALDH1L2 SEL1L3 PLAAT2 LMAN2 WFS1 SND1 ENTPD1 HDLBP | 3.11e-07 | 199 | 331 | 11 | e6422b65e22e5aa8dfaebdae5be76dd78b978604 |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | DCHS2 HRH1 FLG COL11A1 TNC ITIH5 KCNT2 KIRREL1 CD151 CDH6 ALPK2 | 3.11e-07 | 199 | 331 | 11 | b9338b739162cd8e5661c9a4dcb41a31219b5723 |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | DCHS2 HRH1 FLG COL11A1 TNC ITIH5 KCNT2 KIRREL1 CD151 CDH6 ALPK2 | 3.11e-07 | 199 | 331 | 11 | c972d3036151403f26fa9d6271520639c281ab84 |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | A2M DOCK4 MYO10 SPTBN1 QSOX1 FN1 TNC SH3D19 CD44 MACF1 CDH11 | 3.11e-07 | 199 | 331 | 11 | 212e89d097753790061310373a1fafba773488b6 |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | A2M DOCK4 MYO10 SPTBN1 QSOX1 FN1 TNC SH3D19 CD44 MACF1 CDH11 | 3.11e-07 | 199 | 331 | 11 | 14b676aa289c0578a37be32cec3ea285c79d97cc |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.11e-07 | 199 | 331 | 11 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Alveolar_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | DCHS2 FREM1 FN1 ZSCAN5A ADGRA2 ITIH5 GXYLT2 ENTPD6 CDH11 UNC80 | 4.89e-07 | 166 | 331 | 10 | 65dafed953b01a9830b54309af75c7a561e88336 |
| ToppCell | COVID-19-kidney-PEC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.46e-07 | 168 | 331 | 10 | a086c306be430adf0632ba53e98cd8014d2de330 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 6.42e-07 | 171 | 331 | 10 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-plasmacytoid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CHDH SLCO4A1 CEP128 CD300C HRH1 CALCOCO1 TAF6L KDM4A PNCK CYTH4 | 7.15e-07 | 173 | 331 | 10 | 1b9b4e165121b08ef15a93fca6bea875cae69f19 |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Plasmacytoid_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CHDH SLCO4A1 CEP128 CD300C HRH1 CALCOCO1 TAF6L KDM4A PNCK CYTH4 | 7.15e-07 | 173 | 331 | 10 | c25f24d7b672c9686d31ebc8d263042282f520fd |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | CAPN12 MYO7B CHDH MAST4 TRPM3 ALDH6A1 MFSD2A LRP2 CDH6 ALPK2 | 9.76e-07 | 179 | 331 | 10 | d1ef7e1cb00336118e387b47f4f8120f53584391 |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.03e-06 | 180 | 331 | 10 | f2f6e83127a4a415e65c76a35efa8175fbd5b5d9 | |
| ToppCell | COVID-19-kidney-PCT-S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.03e-06 | 180 | 331 | 10 | 358923e4228035a3e90e2957392089219e90dcd7 | |
| ToppCell | Epithelial-lung_neuroendocrine_cell_(PNEC)|World / Lineage, Cell type, age group and donor | ADCY2 DSCAML1 RUNDC3A NALCN SYT1 UNC5D SPTBN4 INA POTEJ UNC80 | 1.13e-06 | 182 | 331 | 10 | 57bf4ffb304324e2e392e196336a530d9f78fe0d |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | CAPN12 DCHS2 MYO7B SLCO4A1 TRPM3 ALDH6A1 LRRC4C AGPS LRP2 ALPK2 | 1.19e-06 | 183 | 331 | 10 | d73cac83cde82665f110baad7cf28db75f9ffe52 |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.25e-06 | 184 | 331 | 10 | fe9ea4d0e0be820e95eaf9bb42a5560d0e177574 | |
| ToppCell | COVID-19-kidney-PCT-S1|kidney / Disease (COVID-19 only), tissue and cell type | 1.25e-06 | 184 | 331 | 10 | 51ed1ebfdef45149541917c66cbacad87072e51f | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-06 | 185 | 331 | 10 | cdd75abdaa1ecedfd2e636203b83a6ac1782f0c3 | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 1.32e-06 | 185 | 331 | 10 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | Myeloid-B_(Activated_Macrophage)|World / shred on cell class and cell subclass (v4) | 1.38e-06 | 186 | 331 | 10 | 33d731a7883d75e4e7db83b641cdb1e9a39938bf | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-06 | 186 | 331 | 10 | 8287146f0ba415ea04475588117d4668ae00f75c | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 1.38e-06 | 186 | 331 | 10 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.38e-06 | 186 | 331 | 10 | 7950e03ea080238c168b9d807e217f459acdfb28 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | HDHD3 ADCY2 MAST4 TRPM3 GLDC SYNE2 PLEKHA7 LRP2 PLEKHA1 ALPK2 | 1.38e-06 | 186 | 331 | 10 | b1edc341d6684b347dc9e21b34f62f51d095d735 |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | CAPN12 MYO7B CHDH ADCY2 DSCAML1 SEL1L3 UNC5D LRP2 CDH6 ALPK2 | 1.38e-06 | 186 | 331 | 10 | f28d72b47624b69a580b4429e2be560a26898591 |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.45e-06 | 187 | 331 | 10 | 1b82920588f9e26ef1db244d452736d75fcfd342 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.45e-06 | 187 | 331 | 10 | 71eb26ebf60cb0848e5bf1cd01edccda621aecd8 | |
| ToppCell | COVID-19-kidney-Stressed_PCT|kidney / Disease (COVID-19 only), tissue and cell type | 1.45e-06 | 187 | 331 | 10 | acd305475f3609800af0d7bc68d83ef41228080b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.45e-06 | 187 | 331 | 10 | c1e4c0345f9bfa0538730bad5ff3fa5240168b25 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-06 | 187 | 331 | 10 | 14c239af77116d28d511dea754b6150d20488080 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | ADAMTS19 GAD1 MYO10 CEP128 FREM1 FREM2 NRXN3 CD44 KIRREL1 EML1 | 1.52e-06 | 188 | 331 | 10 | b070a0667f1ee9b825b267b6c389b7c42fc436f9 |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | PDE3B SPTAN1 SPTBN1 ACVR2A CEMIP2 USP42 ATXN1 SYNE2 LRRK1 MACF1 | 1.67e-06 | 190 | 331 | 10 | 91ba66d4b56c59523485b17738e93f14bb00afa4 |
| ToppCell | PBMC-Severe-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | CEP128 PGM3 GLDC ALDH1L2 SEL1L3 PLAAT2 WFS1 SND1 ENTPD1 HDLBP | 1.67e-06 | 190 | 331 | 10 | 84eb7761f537d270673909a71d4f122e826769d5 |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.67e-06 | 190 | 331 | 10 | f85cdd79eefd699ada7a91bf4997cc730a9b9846 | |
| ToppCell | Control-Endothelial-VE_Venous|Endothelial / Disease state, Lineage and Cell class | 1.67e-06 | 190 | 331 | 10 | 4e30155203b4a8c5e496fcbe9348b67b98ebc625 | |
| ToppCell | PBMC-Severe-cDC_12|Severe / Compartment, Disease Groups and Clusters | 1.67e-06 | 190 | 331 | 10 | 84ee185939bdefb10705b621a70da27701eadcee | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | FREM2 MAST4 SEL1L3 COL11A1 MAGI3 LRRC4C NTN4 MFSD2A USP54 LRRC36 | 1.76e-06 | 191 | 331 | 10 | 34cc997e4e5c727495f321e6807a84aa124da486 |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.76e-06 | 191 | 331 | 10 | 1c1d13144259b998d4a0e85142f7afef2ef1e63f | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.76e-06 | 191 | 331 | 10 | 5d24022cec293bc8d9e978ae99a109e660bb8f83 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.76e-06 | 191 | 331 | 10 | 73dae4cdea86aec62393ad7303dc7375a6b3fc86 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.76e-06 | 191 | 331 | 10 | 3c464645d0e7e423f791bd63bf5bcf11f6b590d3 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 1.76e-06 | 191 | 331 | 10 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.84e-06 | 192 | 331 | 10 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | SEPTIN9 CEMIP2 NFATC2 SEL1L3 HRH1 ABCC1 RASA3 TNC CD44 MACF1 | 1.84e-06 | 192 | 331 | 10 | 8b86db2ebe0199fee0e9800566a619a24bfdeed5 |
| ToppCell | CD8+_Memory_T_cell-CV-0|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | PDE3B SPTAN1 JAK1 ATXN1 SYNE2 NCR1 SPSB3 CALCOCO1 PLEKHA1 ATM | 1.93e-06 | 193 | 331 | 10 | 995781d87a919c0380750878bafe584342bb83ad |
| ToppCell | droplet-Pancreas-Endocrine-21m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | PPM1J FREM1 S100B SERPINB8 IL33 ADAMTS3 KRT79 ADGRA2 TNFAIP6 CDH11 | 1.93e-06 | 193 | 331 | 10 | 59b8186d0221fba06a16157e9d148399ed801f38 |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-SST-MGE1-4|World / Primary Cells by Cluster | 1.93e-06 | 193 | 331 | 10 | 2eb6e4cff4fe3ce564c1581f6f7df4834895aaa9 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | PPM1J FREM1 S100B SERPINB8 IL33 ADAMTS3 KRT79 ADGRA2 TNFAIP6 CDH11 | 1.93e-06 | 193 | 331 | 10 | dc92680b4bb9fc26430c92e03adb839c8c3b3b98 |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | GLDC KLHL13 SYNE2 HRH1 KAZN PLEKHA7 NTN4 DNAI4 PLEKHA1 KIRREL1 | 1.93e-06 | 193 | 331 | 10 | 42df7ed37d11fb542b4d1d714b6f87ae8e1396a6 |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | GLDC KLHL13 SYNE2 HRH1 KAZN PLEKHA7 NTN4 DNAI4 PLEKHA1 KIRREL1 | 1.93e-06 | 193 | 331 | 10 | f42a0f02ed00fe1bb833ff0a0640d9131bca89bd |
| ToppCell | droplet-Pancreas-Endocrine-21m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | PPM1J FREM1 S100B SERPINB8 IL33 ADAMTS3 KRT79 ADGRA2 TNFAIP6 CDH11 | 1.93e-06 | 193 | 331 | 10 | 03678162648bd5b1d65a5450b60c8863edbf95c7 |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | DSCAML1 KLHL13 SYNE2 HRH1 KAZN PLEKHA7 NTN4 DNAI4 PLEKHA1 KIRREL1 | 2.02e-06 | 194 | 331 | 10 | e577d9e88390b36b5a09b97fe1026089892275a3 |
| ToppCell | CF-Myeloid-cDC|Myeloid / Disease state, Lineage and Cell class | A2M HLA-DPA1 CEP128 S100B NFATC2 SEL1L3 ARHGAP5 ENTPD1 MTR ABHD12 | 2.02e-06 | 194 | 331 | 10 | 3feb8a0ba3368673c53e9cbd4980e73d18697718 |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.02e-06 | 194 | 331 | 10 | 99577a5a631e607b5abe7a1b0d8d6a5eabe50196 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.02e-06 | 194 | 331 | 10 | 8ddcaaf24cee6e30d5be52c0cbf778cfba309c53 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-06 | 196 | 331 | 10 | 2b36b9a40fe415917afccff99ad9c3474e087d0d | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-06 | 196 | 331 | 10 | 023477a499a2c190f363cfdbc9d9c646733a6541 | |
| ToppCell | 367C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | ATP8B4 HLA-DPA1 ABCA9 S100B NFATC2 MERTK ENTPD1 DIP2C CYTH4 ADAP2 | 2.21e-06 | 196 | 331 | 10 | e8c4eeb4b6c6d9bccca2adb942d4cfbaab39636c |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | STRBP SPTBN1 CEMIP2 SYNE2 SEL1L3 CNOT6L CD22 ZBTB10 ATM RPL13 | 2.21e-06 | 196 | 331 | 10 | c225c8eb2fe9a10f0cf574c7d8b6206887aac2df |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-06 | 196 | 331 | 10 | 3cb74f1a333a82cac2b459f2f1517e2acf22b5fd | |
| ToppCell | COVID-19-lung-Capillary_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | DOCK4 PDE3B SPTBN1 SLCO4A1 SNRK DYSF CEMIP2 NRXN3 GNA14 SH3D19 | 2.21e-06 | 196 | 331 | 10 | ac28e9be288af6f00a841aea4ce4b99aed6b4505 |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | ADAMTS19 DCHS2 HRH1 FLG COL11A1 TNC ITIH5 KCNT2 KIRREL1 CDH6 | 2.21e-06 | 196 | 331 | 10 | 545d2e4469924d333e3f655f559c899fa1260196 |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 2.32e-06 | 197 | 331 | 10 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 2.32e-06 | 197 | 331 | 10 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| Computational | Neighborhood of CDKN1C | 8.96e-06 | 27 | 203 | 6 | GNF2_CDKN1C | |
| Computational | Neighborhood of EGFR | 2.53e-05 | 32 | 203 | 6 | GNF2_EGFR | |
| Computational | Neighborhood of IGFBP1 | 4.33e-05 | 35 | 203 | 6 | GNF2_IGFBP1 | |
| Computational | Neighborhood of MMP11 | 1.25e-04 | 42 | 203 | 6 | GNF2_MMP11 | |
| Computational | Neighborhood of TIMP2 | 2.10e-04 | 46 | 203 | 6 | GNF2_TIMP2 | |
| Computational | Neighborhood of KISS1 | 3.00e-04 | 49 | 203 | 6 | GNF2_KISS1 | |
| Drug | AC1L1IPV | 1.71e-07 | 43 | 331 | 8 | CID000004683 | |
| Drug | Tiletamine hydrochloride; Down 200; 15.4uM; PC3; HT_HG-U133A | USP34 B4GALT7 RTEL1 SNRK ADA SERPINB8 ANAPC5 ABCC1 CNTRL SMG5 ARHGAP35 BTN3A2 WDR19 TAF6L YLPM1 | 2.43e-07 | 199 | 331 | 15 | 7311_DN |
| Drug | Homochlorcyclizine dihydrochloride [1982-36-1]; Down 200; 10.4uM; MCF7; HT_HG-U133A | GAD1 MAN2C1 SPTAN1 WDR76 ADA ZNF623 KAT8 KAZN FN1 MSANTD2 SMG5 PPP5C EML1 RPL13 | 1.04e-06 | 194 | 331 | 14 | 5998_DN |
| Drug | Gabapentin [60142-96-3]; Up 200; 23.4uM; MCF7; HT_HG-U133A | EPOR SEPTIN9 SPTAN1 VPS26C SRCAP NEB WDR76 KAZN CALCOCO1 ST3GAL2 ARHGAP35 ENTPD4 ATM ADAP2 | 1.10e-06 | 195 | 331 | 14 | 3472_UP |
| Drug | (+/-)-blebbistatin; Up 200; 17uM; MCF7; HT_HG-U133A_EA | NEB PAPOLA ATXN1 USP7 ABCC1 ARHGAP35 GNA14 PPP5C SND1 CD44 LRP2 HMGXB3 KDM4A | 5.69e-06 | 194 | 331 | 13 | 954_UP |
| Drug | Lumicolchicine gamma [6901-14-0]; Down 200; 10uM; MCF7; HT_HG-U133A | USP34 EPOR PCDHA9 RTEL1 SEPTIN9 SRCAP WDR76 MAST4 PARP16 KAT8 SECTM1 CALCOCO1 ATM | 6.02e-06 | 195 | 331 | 13 | 3254_DN |
| Drug | Phenindione [83-12-5]; Down 200; 18uM; MCF7; HT_HG-U133A | USP34 EPOR PDE3B SPTAN1 SRCAP DOCK5 PAPOLA PARP16 ZNF574 ENTPD4 PAPOLG YLPM1 ATM | 6.73e-06 | 197 | 331 | 13 | 2868_DN |
| Drug | Disulfiram [97-77-8]; Down 200; 13.4uM; PC3; HT_HG-U133A | EPOR SPTBN1 SRCAP ADA PIK3CB PARP16 MERTK FN1 CORO2A TNC BTN3A2 LRP2 ADAP2 | 7.11e-06 | 198 | 331 | 13 | 5729_DN |
| Drug | Molindone hydrochloride [15622-65-8]; Up 200; 12.8uM; HL60; HT_HG-U133A | TBKBP1 ACACB RTEL1 SEPTIN9 SPTAN1 NEB CEMIP2 USP7 NOS1 FN1 ARHGAP35 RHAG DNAI4 | 7.11e-06 | 198 | 331 | 13 | 2917_UP |
| Drug | 0317956-0000 [391210-11-0]; Up 200; 1uM; PC3; HT_HG-U133A | MYO10 SPTBN1 ADCY2 TRPM3 FN1 AAK1 ARHGAP35 ADGRA2 RHAG PAPOLG LIPE KIRREL1 CDH6 | 7.51e-06 | 199 | 331 | 13 | 4334_UP |
| Drug | N-Ac-D-E | 1.12e-05 | 53 | 331 | 7 | CID000005255 | |
| Drug | ICRF-193 | 1.27e-05 | 54 | 331 | 7 | CID000115150 | |
| Drug | Dobutamine hydrochloride [49745-95-1]; Up 200; 11.8uM; PC3; HT_HG-U133A | GAD1 PRODH2 MAST4 PAPOLA ALDH6A1 IL33 TNC MUC5B SMG5 BTN3A2 SND1 MUC5AC | 1.81e-05 | 185 | 331 | 12 | 6286_UP |
| Drug | TTNPB; Up 200; 0.1uM; MCF7; HG-U133A | ACACB SRCAP DYSF RUNDC3A KAZN RAD52 CORO2A ICAM2 GRIN2B ADGRA2 CD22 ENTPD1 | 2.35e-05 | 190 | 331 | 12 | 223_UP |
| Drug | tert-butyl hydroperoxide | DOCK4 KNTC1 GALNT1 MYO10 SPTBN1 MCM6 RETSAT UBA7 SERPINB8 PAPOLA ATXN1 NFE2L1 SEL1L3 SYT1 GAPDHS ANAPC5 ALDH6A1 TOP3B AP3D1 SECTM1 KRT1 FN1 NGB POLD1 SLC25A16 DIP2C LRP6 ATM CDH11 TOP2B | 2.40e-05 | 902 | 331 | 30 | CID000006410 |
| Drug | ADPribulose | 2.83e-05 | 13 | 331 | 4 | CID000197570 | |
| Drug | Azaguanine-8 [134-58-7]; Down 200; 26.2uM; MCF7; HT_HG-U133A | SPTAN1 VPS26C TUBGCP2 WDR76 MAP3K4 SMARCAL1 CALCOCO1 ST3GAL2 YLPM1 MACF1 CDK5RAP2 ATM | 2.89e-05 | 194 | 331 | 12 | 1670_DN |
| Drug | PHA-00846566E [724718-26-7]; Up 200; 10uM; PC3; HT_HG-U133A | EPOR ACACB SNRK SYT1 ANAPC5 ALDH6A1 CNTRL BTN3A2 PAPOLG ARHGAP5 CIAO3 ATM | 2.89e-05 | 194 | 331 | 12 | 7086_UP |
| Drug | LY 294002; Up 200; 10uM; PC3; HT_HG-U133A | ZNF623 MAST4 ATXN1 MERTK ALDH6A1 IL33 SPSB3 CALCOCO1 MUC5B WDR19 ZBTB10 MUC5AC | 2.89e-05 | 194 | 331 | 12 | 1239_UP |
| Drug | Menadione [58-27-5]; Down 200; 23.2uM; PC3; HT_HG-U133A | DOCK4 ACACB PEG3 SNRK ADA SYT1 KATNIP PANK3 CAPN2 ARHGAP35 SND1 PRKDC | 2.89e-05 | 194 | 331 | 12 | 4662_DN |
| Drug | Flunisolide [3385-03-3]; Down 200; 9.2uM; MCF7; HT_HG-U133A | SPTAN1 SNRK SRCAP NEB DYSF PLAAT2 SPSB3 WDR48 RAD52 ST3GAL2 ENTPD1 ATM | 2.89e-05 | 194 | 331 | 12 | 3828_DN |
| Drug | Trimeprazine tartrate [4330-99-8]; Up 200; 5.4uM; MCF7; HT_HG-U133A | EPOR PDE3B B4GALT7 TBKBP1 ACACB NCR1 ZNF574 CALCOCO1 AAK1 ST3GAL2 TAF5L CDH11 | 3.04e-05 | 195 | 331 | 12 | 3478_UP |
| Drug | aspirin, USP; Down 200; 100uM; MCF7; HT_HG-U133A | USP34 EPOR PDE3B VPS26C ZNF623 SYT1 CALCOCO1 ST3GAL2 YLPM1 CD44 HMGXB3 ATM | 3.20e-05 | 196 | 331 | 12 | 1629_DN |
| Drug | Lactobionic acid [96-82-2]; Down 200; 11.2uM; PC3; HT_HG-U133A | GAD1 TUBGCP2 PAPOLA PIK3CB HRH1 FN1 TNC AAK1 SMG5 ARHGAP35 ENTPD1 MUC5AC | 3.20e-05 | 196 | 331 | 12 | 6605_DN |
| Drug | Dosulepin hydrochloride [897-15-4]; Up 200; 12uM; HL60; HG-U133A | DOCK4 SLCO4A1 VPS26C ATXN1 HRH1 FN1 BTN3A2 INA ENTPD6 YLPM1 CD44 HMGXB3 | 3.20e-05 | 196 | 331 | 12 | 1713_UP |
| Drug | Iopamidol [60166-93-0]; Up 200; 5.2uM; MCF7; HT_HG-U133A | EPOR SPTAN1 WDR76 ZNF623 ALDH6A1 CALCOCO1 ST3GAL2 ENTPD4 TAF6L PLEKHA1 ATM HDLBP | 3.20e-05 | 196 | 331 | 12 | 3473_UP |
| Drug | Azlocillin sodium salt [37091-65-9]; Down 200; 8.2uM; MCF7; HT_HG-U133A | PDE3B SPTBN1 NEB ATXN1 KAT8 AP3D1 SMG5 PAPOLG GNA14 CD22 CD44 KDM4A | 3.20e-05 | 196 | 331 | 12 | 3468_DN |
| Drug | Flupentixol dihydrochloride cis-(Z) [2413-38-9]; Down 200; 7.8uM; PC3; HT_HG-U133A | USP34 SPTAN1 SPTBN1 PIK3CB USP7 AP3D1 RAD52 ABCC1 CAPN2 GNA14 CD44 LRP6 | 3.20e-05 | 196 | 331 | 12 | 6708_DN |
| Drug | Thiamine hydrochloride [67-03-8]; Up 200; 11.8uM; HL60; HG-U133A | KIF21B RTEL1 SEPTIN9 RUNDC3A TRPM3 KAT8 SYT1 ANAPC5 FN1 ICAM2 GUCY2D ENTPD1 | 3.20e-05 | 196 | 331 | 12 | 1744_UP |
| Drug | Alfadolone acetate [23930-37-2]; Down 200; 10.2uM; HL60; HT_HG-U133A | SPTAN1 SPTBN1 KAZN CHST7 ICAM2 AAK1 LRRK1 TAF6L ENTPD1 LRP2 LRP6 RPL13 | 3.36e-05 | 197 | 331 | 12 | 3127_DN |
| Drug | Myricetin [529-44-2]; Down 200; 12.6uM; MCF7; HT_HG-U133A | SPTAN1 ZNF623 KAZN RAD52 CNTRL CALCOCO1 ARHGAP35 SLC25A16 TAF6L ATM CDH6 ADAP2 | 3.36e-05 | 197 | 331 | 12 | 3270_DN |
| Drug | Pindolol [13523-86-9]; Down 200; 16.2uM; HL60; HG-U133A | B4GALT7 TUBGCP2 ACVR2A MERTK AP3D1 UBE2NL FN1 ZSCAN5A DNAJC11 ENTPD6 RPL13 HDLBP | 3.36e-05 | 197 | 331 | 12 | 1392_DN |
| Drug | Homatropine hydrobromide (R,S) [51-56-9]; Down 200; 11.2uM; HL60; HT_HG-U133A | EPOR SRCAP DOCK5 USP7 ALDH6A1 ZNF574 UBE2NL CAPN2 AAK1 CIAO3 ENTPD1 CTNNBL1 | 3.36e-05 | 197 | 331 | 12 | 1848_DN |
| Drug | Pralidoxime chloride [51-15-0]; Down 200; 23.2uM; MCF7; HT_HG-U133A | DOCK4 EPOR PDE3B CEMIP2 DOCK5 SEL1L3 ALDH6A1 SPSB3 ZNF574 UBE2NL YLPM1 ATM | 3.36e-05 | 197 | 331 | 12 | 6443_DN |
| Drug | Cephapirin sodium salt [24356-60-3]; Down 200; 9uM; MCF7; HT_HG-U133A | SEPTIN9 MAST4 SECTM1 RAD52 FN1 TAF6L CD22 ENTPD1 LRP6 KDM4A ATM CDH6 | 3.53e-05 | 198 | 331 | 12 | 6790_DN |
| Drug | 1-anilino-4-methyl-2-methylthio-4-phenylimidazolin-5-one | GAD1 GAD2 NRXN3 SYT1 SARDH PLEKHA7 COL11A1 FN1 TNC FRMD8 LRRK1 GXYLT2 ASS1 LRP2 KIRREL1 CD151 PHLDB2 | 3.67e-05 | 373 | 331 | 17 | ctd:C540355 |
| Drug | Isoconazole [27523-40-6]; Down 200; 9.6uM; MCF7; HT_HG-U133A | EPOR SPTBN1 ASB9 KAZN SPSB3 WDR48 FN1 SMG5 WDR19 LRP6 HMGXB3 RPL13 | 3.71e-05 | 199 | 331 | 12 | 7211_DN |
| Drug | Diphemanil methylsulfate [62-97-5]; Up 200; 10.2uM; HL60; HG-U133A | NDUFA1 SRCAP CD300C TRPM3 PARP16 HRH1 GNB3 MSANTD2 PPP5C DIP2C MACF1 ATM | 3.71e-05 | 199 | 331 | 12 | 1994_UP |
| Drug | Urapidil hydrochloride [64887-14-5]; Down 200; 9.4uM; HL60; HT_HG-U133A | A2M B4GALT7 MYO10 SPTAN1 NEB HRH1 ANAPC5 SPSB3 CAPN2 ICAM2 LRP6 CD151 | 3.90e-05 | 200 | 331 | 12 | 3078_DN |
| Drug | AC1L97HB | 4.56e-05 | 45 | 331 | 6 | CID000439504 | |
| Drug | Rgd Peptide | PSG2 PSG3 PSG4 PSG5 MYO10 PSG7 PSG9 PSG11 GLB1 FN1 TNC ENTPD1 CD44 | 5.18e-05 | 239 | 331 | 13 | CID000104802 |
| Drug | PRODAN | 5.28e-05 | 15 | 331 | 4 | CID000028127 | |
| Drug | thiokynurenic acid | 5.28e-05 | 15 | 331 | 4 | CID003035667 | |
| Drug | STOCK1N-35696; Up 200; 15uM; MCF7; HT_HG-U133A | GAD1 RTEL1 VPS26C RETSAT CEMIP2 PAPOLA KAZN SECTM1 SND1 ENTPD6 LRP6 | 7.64e-05 | 182 | 331 | 11 | 6577_UP |
| Drug | Withaferin A [5119-48-2]; Down 200; 1uM; MCF7; HT_HG-U133A | PDE3B RTEL1 SPTBN1 RUNDC3A MAST4 PLAAT2 MERTK PPP5C CD22 ENTPD1 ATM | 9.28e-05 | 186 | 331 | 11 | 3902_DN |
| Drug | 3-bromopropionate | 1.02e-04 | 7 | 331 | 3 | CID000011553 | |
| Drug | prinomastat | 1.07e-04 | 33 | 331 | 5 | CID000466151 | |
| Drug | thiocholine | 1.14e-04 | 18 | 331 | 4 | CID000012234 | |
| Drug | im b | 1.14e-04 | 18 | 331 | 4 | CID000405731 | |
| Drug | Methantheline bromide [53-46-3]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 1.23e-04 | 192 | 331 | 11 | 6254_DN | |
| Drug | Hydrochlorothiazide [58-93-5]; Down 200; 13.4uM; PC3; HT_HG-U133A | EPOR HDHD3 SEPTIN9 PIK3CB ANAPC5 PANK3 AAK1 LRRK1 ENTPD1 LRP6 KIRREL1 | 1.29e-04 | 193 | 331 | 11 | 6625_DN |
| Drug | indomethacin, USP; Up 200; 20uM; MCF7; HG-U133A | A2M EPOR SEPTIN9 SPTBN1 PDZD7 NOS1 AP3D1 SPSB3 ARHGAP35 ADGRA2 ATM | 1.29e-04 | 193 | 331 | 11 | 262_UP |
| Drug | Acetopromazine maleate salt [3598-37-6]; Down 200; 9uM; MCF7; HT_HG-U133A | MYO10 WDR76 PARP16 KAT8 USP7 ALDH6A1 ST3GAL2 TAF6L PPP5C LRP6 ATM | 1.35e-04 | 194 | 331 | 11 | 6832_DN |
| Drug | catechin; Up 200; 11uM; MCF7; HT_HG-U133A_EA | PDE3B SLCO4A1 ACVR2A ATXN1 MORC4 ARHGAP5 PPP5C CD44 HMGXB3 ATM TAF5L | 1.35e-04 | 194 | 331 | 11 | 1101_UP |
| Drug | (R) -Naproxen sodium salt [26159-34-2]; Down 200; 15.8uM; MCF7; HT_HG-U133A | EPOR PDE3B WDR76 PLAAT2 ZNF574 CALCOCO1 ST3GAL2 ENTPD4 ENTPD1 ATM RPL13 | 1.35e-04 | 194 | 331 | 11 | 6794_DN |
| Drug | Nafcillin sodium salt monohydrate [7177-50-6]; Down 200; 8.8uM; MCF7; HT_HG-U133A | SEPTIN9 VPS26C WDR76 USP7 TOP3B WDR48 CNTRL ST3GAL2 TAF6L ATM ADAP2 | 1.41e-04 | 195 | 331 | 11 | 3323_DN |
| Drug | Kaempferol [520-18-3]; Up 200; 14uM; HL60; HT_HG-U133A | MKRN3 GAD2 SPTAN1 SRCAP CEMIP2 PGM3 HRH1 SYT1 GRIN2B ARHGAP35 SLC45A2 | 1.41e-04 | 195 | 331 | 11 | 6157_UP |
| Drug | N-Acetyl-L-leucine [1188-21-2]; Down 200; 23uM; MCF7; HT_HG-U133A | EPOR TUBGCP2 DYSF ZNF623 DOCK5 MERTK SECTM1 SMG5 CD44 LRP6 ADAP2 | 1.48e-04 | 196 | 331 | 11 | 6462_DN |
| Drug | PHA-00851261E [724719-49-7]; Down 200; 1uM; MCF7; HT_HG-U133A | PDE3B SNRK NEB FAM76A ALDH6A1 RAD52 ST3GAL2 SND1 CD22 ATM ADAP2 | 1.48e-04 | 196 | 331 | 11 | 3857_DN |
| Drug | Josamycin [16846-24-5]; Up 200; 4.8uM; MCF7; HT_HG-U133A | MKRN3 GAD1 GAD2 RTEL1 SRCAP PLAAT2 NCR1 SARDH GNA14 INA MUC5AC | 1.48e-04 | 196 | 331 | 11 | 5692_UP |
| Drug | Hyoscyamine (L) [101-31-5]; Down 200; 13.8uM; PC3; HT_HG-U133A | GAD1 HDHD3 VPS26C WDR76 ADA AP3D1 ZNF574 SMG5 YLPM1 CTNNBL1 ATM | 1.48e-04 | 196 | 331 | 11 | 2108_DN |
| Drug | Rolitetracycline [751-97-3]; Up 200; 7.6uM; HL60; HT_HG-U133A | A2M GAD1 ADCY2 RUNDC3A PLAAT2 SECTM1 SEMG1 FN1 NGB RHAG PLEKHA1 | 1.48e-04 | 196 | 331 | 11 | 3031_UP |
| Drug | Metampicillin sodium salt [6489-61-8]; Down 200; 10.4uM; MCF7; HT_HG-U133A | EPOR PDE3B TUBGCP2 WDR76 ABCC1 CNTRL CALCOCO1 ARHGAP35 TAF6L ATM EML1 | 1.48e-04 | 196 | 331 | 11 | 5540_DN |
| Drug | Harmane hydrochloride [21655-84-5]; Down 200; 18.2uM; MCF7; HT_HG-U133A | A2M EPOR GAD1 SEPTIN9 SRCAP DYSF RUNDC3A CNTRL MUC5B GNA14 CDH6 | 1.48e-04 | 196 | 331 | 11 | 4408_DN |
| Drug | Methoxamine hydrochloride [61-16-5]; Down 200; 16.2uM; MCF7; HT_HG-U133A | EPOR PDE3B RTEL1 SRCAP PAPOLA PIK3CB KAZN TOP3B CALCOCO1 ST3GAL2 LRP6 | 1.54e-04 | 197 | 331 | 11 | 2848_DN |
| Drug | Diazoxide [364-98-7]; Down 200; 17.4uM; HL60; HG-U133A | NFE2L1 PARP16 UBE2NL PANK3 SMARCAL1 CALCOCO1 BTN3A2 RHAG ATM TAF5L HDLBP | 1.54e-04 | 197 | 331 | 11 | 1368_DN |
| Drug | Berberine chloride [633-65-8]; Up 200; 10.8uM; HL60; HG-U133A | PDE3B B4GALT7 DYSF RUNDC3A SARDH AAK1 SMG5 GRIN2B ARHGAP35 ENTPD1 SLC45A2 | 1.54e-04 | 197 | 331 | 11 | 1778_UP |
| Drug | 2-propylpentanoic acid; Down 200; 1000uM; MCF7; HT_HG-U133A | RTEL1 CEMIP2 MAST4 PARP16 SYT1 KATNIP ZNF574 CNTRL TAF6L ATM RPL13 | 1.54e-04 | 197 | 331 | 11 | 1634_DN |
| Drug | Glipizide [29094-61-9]; Down 200; 9uM; MCF7; HT_HG-U133A | PDE3B RTEL1 MYO10 MERTK NOS1 ST3GAL2 ARHGAP35 CD22 LRP2 LRP6 ATM | 1.54e-04 | 197 | 331 | 11 | 1508_DN |
| Drug | Clenbuterol hydrochloride [21898-19-1]; Down 200; 12.8uM; MCF7; HT_HG-U133A | SPTBN1 SRCAP SECTM1 SMARCAL1 CALCOCO1 SMG5 ARHGAP35 TAF6L GNA14 YLPM1 LRP2 | 1.54e-04 | 197 | 331 | 11 | 3228_DN |
| Drug | Pyrithyldione [77-04-3]; Up 200; 24uM; PC3; HT_HG-U133A | GAD1 HDHD3 TUBGCP2 ADA MAST4 AAK1 SMG5 TAF6L CD22 CIAO3 CTNNBL1 | 1.54e-04 | 197 | 331 | 11 | 7153_UP |
| Drug | Oxybenzone [131-57-7]; Down 200; 17.6uM; MCF7; HT_HG-U133A | RTEL1 SRCAP PAPOLA KAT8 KAZN ST3GAL2 ARHGAP35 ENTPD4 SND1 ENTPD1 LRP6 | 1.54e-04 | 197 | 331 | 11 | 5410_DN |
| Drug | 16-phenyl tetranor Prostaglandin E2; Up 200; 10uM; MCF7; HT_HG-U133A | GAD1 PDE3B B4GALT7 MYO10 DOCK5 USP7 MERTK CHST7 SMG6 KRT1 CD44 | 1.54e-04 | 197 | 331 | 11 | 7505_UP |
| Drug | Bupropion hydrochloride [31677-93-7]; Down 200; 14.4uM; MCF7; HT_HG-U133A | SPTBN1 COPS2 MAST4 CHST7 SECTM1 WDR48 SMG5 PAPOLG TAF6L CD44 HMGXB3 | 1.61e-04 | 198 | 331 | 11 | 6256_DN |
| Drug | Danazol [17230-88-5]; Down 200; 11.8uM; MCF7; HT_HG-U133A | USP34 PDE3B MAST4 KAZN WDR48 CNTRL SMG5 TAF6L ENTPD1 LRP6 CDH6 | 1.61e-04 | 198 | 331 | 11 | 1538_DN |
| Drug | Cisapride [81098-60-4]; Down 200; 8.6uM; MCF7; HT_HG-U133A | EPOR PDE3B SRCAP ASB9 TOP3B RAD52 SMG5 ENTPD4 GNA14 CD44 LRP6 | 1.61e-04 | 198 | 331 | 11 | 3305_DN |
| Drug | N-Acetyl-DL-homocysteine Thiolactone [1195-16-0]; Down 200; 25.2uM; MCF7; HT_HG-U133A | ACACB RTEL1 SRCAP DYSF KAT8 TOP3B RAD52 PAPOLG PPP5C CD44 LRP6 | 1.61e-04 | 198 | 331 | 11 | 6031_DN |
| Drug | Trioxsalen [3902-71-4]; Up 200; 17.6uM; MCF7; HT_HG-U133A | PSG11 SRCAP PRODH2 TOP3B TNC CAPN2 ADGRA2 TAF6L PPP5C DNAI4 SLC45A2 | 1.61e-04 | 198 | 331 | 11 | 6078_UP |
| Drug | Rifampicin [13292-46-1]; Down 200; 4.8uM; MCF7; HT_HG-U133A | EPOR MAN2C1 RTEL1 SPTAN1 SRCAP ZNF623 MERTK SPSB3 ABCC1 CALCOCO1 SND1 | 1.61e-04 | 198 | 331 | 11 | 2847_DN |
| Drug | Josamycin [16846-24-5]; Down 200; 4.8uM; MCF7; HT_HG-U133A | PDE3B VPS26C TUBGCP2 MAST4 ASB9 USP7 NOS1 CORO2A CNTRL AAK1 CD44 | 1.61e-04 | 198 | 331 | 11 | 1534_DN |
| Drug | Trolox [53188-07-1]; Down 200; 16uM; PC3; HT_HG-U133A | EPOR RTEL1 ADA MAST4 ZNF574 TNC CNTRL CALCOCO1 TAF6L PPP5C KIRREL1 | 1.61e-04 | 198 | 331 | 11 | 7304_DN |
| Drug | Dicumarol [66-76-2]; Down 200; 11.8uM; MCF7; HT_HG-U133A | EPOR SPTAN1 VPS26C ATXN1 PARP16 CHST7 SPSB3 SMG5 CD44 CDK5RAP2 ATM | 1.61e-04 | 198 | 331 | 11 | 3423_DN |
| Drug | Glycopyrrolate [596-51-0]; Down 200; 10uM; PC3; HT_HG-U133A | USP34 GAD2 TBKBP1 SRCAP MAST4 ALDH6A1 IL33 MUC5B ARHGAP35 CD22 ADAP2 | 1.61e-04 | 198 | 331 | 11 | 3687_DN |
| Drug | estradiol, USP; Up 200; 0.1uM; MCF7; HT_HG-U133A | DOCK4 EPOR GAD1 PDE3B NEB NOS1 PANK3 ST3GAL2 ENTPD1 HMGXB3 ZNF749 | 1.61e-04 | 198 | 331 | 11 | 6968_UP |
| Drug | Dizocilpine maleate [77086-22-7]; Down 200; 11.8uM; PC3; HT_HG-U133A | GAD1 SPTAN1 PEG3 SRCAP KATNIP SMARCAL1 ST3GAL2 BTN3A2 YLPM1 CDK5RAP2 ATM | 1.61e-04 | 198 | 331 | 11 | 2069_DN |
| Drug | Sulfamethoxypyridazine [80-35-3]; Down 200; 14.2uM; MCF7; HT_HG-U133A | EPOR GAD1 TBKBP1 ACACB TUBGCP2 DYSF PAPOLA PIK3CB TAF6L CD44 CDH6 | 1.61e-04 | 198 | 331 | 11 | 3609_DN |
| Drug | Naloxone hydrochloride [357-08-4]; Up 200; 11uM; HL60; HG-U133A | EPOR ACACB SRCAP COPS2 ALDH6A1 FN1 ICAM2 PAPOLG YLPM1 DIP2C CYTH4 | 1.61e-04 | 198 | 331 | 11 | 2006_UP |
| Drug | S x H | 1.64e-04 | 36 | 331 | 5 | CID009549209 | |
| Drug | Pirlindole mesylate [60762-57-4]; Down 200; 12.4uM; HL60; HT_HG-U133A | SEPTIN9 SPTAN1 PLAAT2 KAZN LRRK1 ARHGAP35 ENTPD4 TAF6L CD44 LRP6 CDH6 | 1.69e-04 | 199 | 331 | 11 | 3140_DN |
| Drug | Mebeverine hydrochloride [2753-45-9]; Up 200; 8.6uM; MCF7; HT_HG-U133A | A2M PCDHA9 TBKBP1 SPTAN1 SPTBN1 UBA7 MAST4 USP7 ABCC1 CALCOCO1 ST3GAL2 | 1.69e-04 | 199 | 331 | 11 | 6795_UP |
| Drug | Tolfenamic acid [13710-19-5]; Up 200; 15.2uM; PC3; HT_HG-U133A | USP34 GAD2 TBKBP1 SRCAP MAST4 USP7 LRRK1 TAF6L LIPE CD22 RPL13 | 1.69e-04 | 199 | 331 | 11 | 2120_UP |
| Drug | Flucytosine [2022-85-7]; Up 200; 31uM; HL60; HT_HG-U133A | GAD2 SPTBN1 ADA RUNDC3A SARDH CHST7 NOS1 TOP3B LRRK1 PPP5C CDH11 | 1.69e-04 | 199 | 331 | 11 | 3073_UP |
| Drug | AH6809; Up 200; 1uM; PC3; HT_HG-U133A | B4GALT7 DYSF PAPOLA RAD52 PANK3 CAPN2 CALCOCO1 SMG5 CIAO3 CTNNBL1 KDM4A | 1.69e-04 | 199 | 331 | 11 | 7075_UP |
| Drug | Suxibuzone [27470-51-5]; Up 200; 9.2uM; MCF7; HT_HG-U133A | RTEL1 DYSF SECTM1 RAD52 ABCC1 FN1 CALCOCO1 CD44 SLC45A2 ATM ADAP2 | 1.69e-04 | 199 | 331 | 11 | 7163_UP |
| Drug | Clonidine hydrochloride [4205-91-8]; Down 200; 15uM; PC3; HT_HG-U133A | PCDHA9 TUBGCP2 SRCAP NEB SYT1 IL33 CAPN2 ST3GAL2 SMG5 ARHGAP35 ENTPD1 | 1.69e-04 | 199 | 331 | 11 | 4478_DN |
| Drug | Flurbiprofen [5104-49-4]; Down 200; 16.4uM; MCF7; HT_HG-U133A | DOCK4 USP34 EPOR SRCAP MERTK CALCOCO1 ST3GAL2 PAPOLG GNA14 PPP5C KDM4A | 1.69e-04 | 199 | 331 | 11 | 5634_DN |
| Drug | Demeclocycline hydrochloride [64-73-3]; Up 200; 8uM; MCF7; HT_HG-U133A | GAD1 SPTBN1 SRCAP RUNDC3A PLAAT2 SECTM1 RAD52 ST3GAL2 CDH6 TBL2 CYTH4 | 1.69e-04 | 199 | 331 | 11 | 4728_UP |
| Drug | Promethazine hydrochloride [58-33-3]; Down 200; 12.4uM; MCF7; HT_HG-U133A | GAD1 PCDHA9 TUBGCP2 NEB WDR76 MAST4 RAD52 CD44 LRP6 ATM EML1 | 1.69e-04 | 199 | 331 | 11 | 6477_DN |
| Drug | Methantheline bromide [53-46-3]; Up 200; 9.6uM; MCF7; HT_HG-U133A | GAD1 SPTAN1 SRCAP CD300C UBA7 ST3GAL2 ARHGAP35 ADGRA2 ATM MUC5AC TBL2 | 1.69e-04 | 199 | 331 | 11 | 3560_UP |
| Drug | Fosfosal [6064-83-1]; Up 200; 18.4uM; HL60; HT_HG-U133A | GAD1 GAD2 TUBGCP2 CD300C DOCK5 TRPM3 SYT1 MERTK CHST7 DNAI4 SLC45A2 | 1.76e-04 | 200 | 331 | 11 | 2997_UP |
| Disease | cD177 antigen measurement | 1.11e-06 | 18 | 320 | 5 | EFO_0021866 | |
| Disease | 1,5 anhydroglucitol measurement | 1.39e-05 | 29 | 320 | 5 | EFO_0008009 | |
| Disease | pregnancy-specific beta-1-glycoprotein 4 measurement | 2.47e-05 | 6 | 320 | 3 | EFO_0801907 | |
| Disease | pregnancy-specific beta-1-glycoprotein 3 measurement | 4.28e-05 | 7 | 320 | 3 | EFO_0801906 | |
| Disease | Malignant neoplasm of breast | ADAMTS19 EPOR MAN2C1 STRBP SPTAN1 DYSF PIK3CB SYNE2 ANAPC5 GPI ABCC1 COL11A1 FN1 SMARCAL1 APRT BTN3A2 LIPE INA KCNT2 MTR DIP2C MACF1 ATM USP54 TOP2A TP73 HDLBP | 5.09e-05 | 1074 | 320 | 27 | C0006142 |
| Disease | heart disease (implicated_via_orthology) | 5.44e-05 | 38 | 320 | 5 | DOID:114 (implicated_via_orthology) | |
| Disease | congenital heart disease (implicated_via_orthology) | 1.05e-04 | 69 | 320 | 6 | DOID:1682 (implicated_via_orthology) | |
| Disease | Disorder of eye | PDZD7 FREM1 FREM2 MERTK COL11A1 WFS1 GUCY2D SLC45A2 BBS12 ABHD12 | 1.16e-04 | 212 | 320 | 10 | C0015397 |
| Disease | spastic cerebral palsy (implicated_via_orthology) | 1.17e-04 | 2 | 320 | 2 | DOID:0050669 (implicated_via_orthology) | |
| Disease | level of pregnancy-specific beta-1-glycoprotein 3 in blood serum | 1.17e-04 | 2 | 320 | 2 | OBA_2043058 | |
| Disease | level of pregnancy-specific beta-1-glycoprotein 4 in blood serum | 1.17e-04 | 2 | 320 | 2 | OBA_2043059 | |
| Disease | B cell deficiency (implicated_via_orthology) | 1.17e-04 | 2 | 320 | 2 | DOID:2115 (implicated_via_orthology) | |
| Disease | Marles Greenberg Persaud syndrome | 1.17e-04 | 2 | 320 | 2 | C1855425 | |
| Disease | brain measurement, neuroimaging measurement | PDXDC1 KIF21B ADAMTS19 DCHS2 SPTBN1 TTC34 DSCAML1 MAST4 SYT1 SMG6 COL11A1 ADAMTS3 ITIH5 SND1 ENTPD6 MACF1 EML1 | 1.22e-04 | 550 | 320 | 17 | EFO_0004346, EFO_0004464 |
| Disease | pleural tuberculosis (is_marker_for) | 1.43e-04 | 10 | 320 | 3 | DOID:106 (is_marker_for) | |
| Disease | Seizures | 1.46e-04 | 218 | 320 | 10 | C0036572 | |
| Disease | smoking status measurement, forced expiratory volume | 1.95e-04 | 11 | 320 | 3 | EFO_0004314, EFO_0006527 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 2.22e-04 | 148 | 320 | 8 | C0279702 | |
| Disease | neuroimaging measurement | PDXDC1 KIF21B DCHS2 SPTBN1 FGFRL1 TTC34 DYSF JAK1 MAST4 SYT1 PLEKHA7 SMG6 COL11A1 ADAMTS3 CAPN2 ARHGAP35 SLC25A16 ITIH5 SND1 ENTPD6 MACF1 EML1 ABHD12 TBL2 CDH11 | 2.91e-04 | 1069 | 320 | 25 | EFO_0004346 |
| Disease | fatty liver disease (implicated_via_orthology) | 3.39e-04 | 31 | 320 | 4 | DOID:9452 (implicated_via_orthology) | |
| Disease | visceral adipose tissue measurement, body mass index | 3.75e-04 | 87 | 320 | 6 | EFO_0004340, EFO_0004765 | |
| Disease | Squamous cell carcinoma of lung | 3.84e-04 | 32 | 320 | 4 | C0149782 | |
| Disease | uric acid measurement | USP34 GAD1 TRPM7 ACVR2A KIAA0319 NFATC2 PLAAT2 SYT1 LMAN2 AAK1 TTC27 FRMD8 NTN4 GUCY2D LRP2 DIP2C TBL2 | 4.06e-04 | 610 | 320 | 17 | EFO_0004761 |
| Disease | disease recurrence, unipolar depression, bipolar disorder, schizophrenia, sex interaction measurement | 4.33e-04 | 33 | 320 | 4 | EFO_0003761, EFO_0004952, EFO_0008343, MONDO_0004985, MONDO_0005090 | |
| Disease | spinocerebellar ataxia type 5 (implicated_via_orthology) | 6.93e-04 | 4 | 320 | 2 | DOID:0050882 (implicated_via_orthology) | |
| Disease | trypanosomiasis (biomarker_via_orthology) | 6.93e-04 | 4 | 320 | 2 | DOID:10113 (biomarker_via_orthology) | |
| Disease | pregnancy-specific beta-1-glycoprotein 9 measurement | 6.93e-04 | 4 | 320 | 2 | EFO_0801909 | |
| Disease | Fraser syndrome (implicated_via_orthology) | 6.93e-04 | 4 | 320 | 2 | DOID:0090001 (implicated_via_orthology) | |
| Disease | pantothenate kinase-associated neurodegeneration (implicated_via_orthology) | 6.93e-04 | 4 | 320 | 2 | DOID:3981 (implicated_via_orthology) | |
| Disease | Schizophrenia | DOCK4 GAD1 GAD2 S100B PRODH2 NRXN3 LMAN2L PIK3CB KAT8 HRH1 GNB3 NOS1 TOP3B ADAMTS3 GRIN2B GRM3 WDR11 MTR LRP2 HAGH ATM | 7.15e-04 | 883 | 320 | 21 | C0036341 |
| Disease | sphingomyelin 14:0 measurement | 7.68e-04 | 17 | 320 | 3 | EFO_0010390 | |
| Disease | refractive error | A2M SEPTIN9 CHDH DSCAML1 GNB3 GRIN2B LRRC4C AGPS GUCY2D KIRREL1 ATM | 9.39e-04 | 326 | 320 | 11 | MONDO_0004892 |
| Disease | Manic Disorder | 1.05e-03 | 71 | 320 | 5 | C0024713 | |
| Disease | blood metabolite measurement | 1.08e-03 | 19 | 320 | 3 | EFO_0005664 | |
| Disease | urinary bladder cancer (is_marker_for) | 1.12e-03 | 107 | 320 | 6 | DOID:11054 (is_marker_for) | |
| Disease | liver cancer (is_implicated_in) | 1.15e-03 | 5 | 320 | 2 | DOID:3571 (is_implicated_in) | |
| Disease | cortical thickness | A2M STRBP SPTBN1 FGFRL1 TTC34 DYSF MAST4 SYT1 PLEKHA7 SMG6 COL11A1 ADAMTS3 SMARCAL1 ARHGAP35 ADGRA2 ITIH5 SND1 YLPM1 MACF1 CDK5RAP2 EML1 PCCB ABHD12 CDH11 | 1.18e-03 | 1113 | 320 | 24 | EFO_0004840 |
| Disease | unipolar depression, bipolar disorder, schizophrenia | 1.26e-03 | 20 | 320 | 3 | EFO_0003761, MONDO_0004985, MONDO_0005090 | |
| Disease | Severe Combined Immunodeficiency | 1.26e-03 | 20 | 320 | 3 | C0085110 | |
| Disease | respiratory symptom measurement, COVID-19 | 1.27e-03 | 74 | 320 | 5 | EFO_0007939, MONDO_0100096 | |
| Disease | Intellectual Disability | PGM3 KMT2C LMAN2L TRPM3 KAT8 SYT1 GRIN2B MFSD2A ENTPD1 ASS1 SUPT16H LRP2 MACF1 | 1.31e-03 | 447 | 320 | 13 | C3714756 |
| Disease | urate measurement, bone density | PDE3B PSG2 FREM1 DOCK5 FSIP2 MAST4 GPR149 KAZN RHCG RAD52 MAGI3 LRRC4C ENTPD4 GXYLT2 ASS1 PRKDC | 1.31e-03 | 619 | 320 | 16 | EFO_0003923, EFO_0004531 |
| Disease | Infiltrating duct carcinoma of female breast | 1.45e-03 | 21 | 320 | 3 | C3165106 | |
| Disease | Manic | 1.61e-03 | 78 | 320 | 5 | C0338831 | |
| Disease | Depression, Bipolar | 1.70e-03 | 79 | 320 | 5 | C0005587 | |
| Disease | Diffuse interstitial pulmonary fibrosis | 1.71e-03 | 6 | 320 | 2 | cv:C0085786 | |
| Disease | protein O-linked-mannose beta-1,4-N-acetylglucosaminyltransferase 2 measurement | 1.71e-03 | 6 | 320 | 2 | EFO_0801956 | |
| Disease | glucagon measurement, glucose tolerance test | 1.71e-03 | 6 | 320 | 2 | EFO_0004307, EFO_0008463 | |
| Disease | age at menopause | SLCO4A1 CHUK CHD6 TOP3B ADGRA2 PPP5C DNAJC11 PRKDC PCCB ABHD12 | 1.82e-03 | 302 | 320 | 10 | EFO_0004704 |
| Disease | Colorectal Carcinoma | MKRN3 TRPM7 PEG3 NDUFA1 DSCAML1 ABCA9 KMT2C HRH1 NCR1 ABCC1 FN1 SRSF6 ZSCAN5A POLD1 WRN LRP2 DIP2C | 1.87e-03 | 702 | 320 | 17 | C0009402 |
| Disease | Immunologic Deficiency Syndromes | 1.91e-03 | 23 | 320 | 3 | C0021051 | |
| Disease | response to clopidogrel, cardiovascular event measurement | 1.91e-03 | 23 | 320 | 3 | EFO_0006919, GO_1903493 | |
| Disease | Ovarian Serous Adenocarcinoma | 1.91e-03 | 23 | 320 | 3 | C1335177 | |
| Disease | colorectal cancer (is_implicated_in) | 2.10e-03 | 121 | 320 | 6 | DOID:9256 (is_implicated_in) | |
| Disease | asthma, Eczema, allergic rhinitis | 2.10e-03 | 121 | 320 | 6 | EFO_0005854, HP_0000964, MONDO_0004979 | |
| Disease | lung squamous cell carcinoma (is_implicated_in) | 2.16e-03 | 24 | 320 | 3 | DOID:3907 (is_implicated_in) | |
| Disease | snoring measurement | 2.23e-03 | 84 | 320 | 5 | EFO_0008341 | |
| Disease | Autistic Disorder | 2.32e-03 | 261 | 320 | 9 | C0004352 | |
| Disease | peritonitis (biomarker_via_orthology) | 2.38e-03 | 7 | 320 | 2 | DOID:8283 (biomarker_via_orthology) | |
| Disease | disease of cellular proliferation (implicated_via_orthology) | 2.38e-03 | 7 | 320 | 2 | DOID:14566 (implicated_via_orthology) | |
| Disease | Angle Closure Glaucoma | 2.38e-03 | 7 | 320 | 2 | C0017605 | |
| Disease | MASA syndrome (implicated_via_orthology) | 2.38e-03 | 7 | 320 | 2 | DOID:0060246 (implicated_via_orthology) | |
| Disease | Squamous cell carcinoma | 2.38e-03 | 124 | 320 | 6 | C0007137 | |
| Disease | Involutional paraphrenia | 2.43e-03 | 25 | 320 | 3 | C1571983 | |
| Disease | Psychosis, Involutional | 2.43e-03 | 25 | 320 | 3 | C1571984 | |
| Disease | Involutional Depression | 2.43e-03 | 25 | 320 | 3 | C0011574 | |
| Disease | psychosis predisposition measurement | 2.73e-03 | 26 | 320 | 3 | EFO_0008337 | |
| Disease | Metastatic melanoma | 2.80e-03 | 54 | 320 | 4 | C0278883 | |
| Disease | facial morphology | 3.00e-03 | 55 | 320 | 4 | EFO_0004743 | |
| Disease | Abnormality of refraction | SMG1 PCDHA9 SEPTIN9 CHDH DSCAML1 GNB3 PCDHA12 PCDHA11 PCDHA3 GRIN2B LRRC4C API5 GRM3 MFSD2A ENTPD6 KIRREL1 | 3.01e-03 | 673 | 320 | 16 | HP_0000539 |
| Disease | Unilateral agenesis of kidney | 3.14e-03 | 8 | 320 | 2 | C0266294 | |
| Disease | female breast cancer (is_implicated_in) | 3.14e-03 | 8 | 320 | 2 | DOID:0050671 (is_implicated_in) | |
| Disease | cesarean section, anxiety | 3.14e-03 | 8 | 320 | 2 | EFO_0005230, EFO_0009636 | |
| Disease | Ataxias, Hereditary | 3.14e-03 | 8 | 320 | 2 | C0004138 | |
| Disease | testosterone measurement | DOCK4 UBR1 DCHS2 SEPTIN9 AKR1D1 FGFRL1 SRCAP WDR76 DOCK5 SERPINB8 SYNE2 USP7 LMAN2 KAZN UNC5D CASC3 ADAMTS3 TTC27 LIPE WDR11 ZBTB10 MACF1 PCCB TBL2 LRRC36 | 3.35e-03 | 1275 | 320 | 25 | EFO_0004908 |
| Disease | lung small cell carcinoma (is_implicated_in) | 3.39e-03 | 28 | 320 | 3 | DOID:5409 (is_implicated_in) | |
| Disease | Myopia | DYSF DSCAML1 TRPM3 KATNIP GNB3 COL11A1 GRIN2B LRRC4C GRM3 MFSD2A KIRREL1 | 3.44e-03 | 385 | 320 | 11 | HP_0000545 |
| Disease | cortical surface area measurement, neuroimaging measurement | 3.50e-03 | 227 | 320 | 8 | EFO_0004346, EFO_0010736 | |
| Disease | lifestyle measurement, anxiety disorder measurement | 3.90e-03 | 137 | 320 | 6 | EFO_0007795, EFO_0010724 | |
| Disease | Liver Diseases, Parasitic | 4.01e-03 | 9 | 320 | 2 | C0023897 | |
| Disease | retinal layer thickness measurement | 4.11e-03 | 60 | 320 | 4 | EFO_0600002 | |
| Disease | Depressive disorder | 4.53e-03 | 289 | 320 | 9 | C0011581 | |
| Disease | Adenoid Cystic Carcinoma | 4.73e-03 | 100 | 320 | 5 | C0010606 | |
| Disease | alcohol consumption measurement | CAPN12 ACACB CHDH SPTBN1 WDR76 NRXN3 MAST4 NFATC2 ATXN1 EPHX4 ZNF574 PMM1 CALCOCO1 MAGI3 GRIN2B LRRC4C GRM3 INSYN2A WDR19 NBAS SND1 TKT CDK5RAP2 CDH11 | 4.80e-03 | 1242 | 320 | 24 | EFO_0007878 |
| Disease | aspartate aminotransferase measurement | KIF21B TRPM7 HLA-DPA1 MCM6 ALKBH5 GLB1 TRPM3 ATXN1 NFE2L1 KAZN MERTK SMG6 ARHGAP35 KRT79 SND1 WDR11 HMGXB3 LY75 ALPK2 | 4.92e-03 | 904 | 320 | 19 | EFO_0004736 |
| Disease | vesicular integral-membrane protein VIP36 measurement | 4.98e-03 | 10 | 320 | 2 | EFO_0022012 | |
| Disease | refractive error, age at onset, Myopia | 5.28e-03 | 193 | 320 | 7 | EFO_0004847, HP_0000545, MONDO_0004892 | |
| Disease | Hypoxemia | 5.42e-03 | 33 | 320 | 3 | C0700292 | |
| Disease | Hypoxia | 5.42e-03 | 33 | 320 | 3 | C0242184 | |
| Disease | Anoxemia | 5.42e-03 | 33 | 320 | 3 | C0003129 | |
| Disease | Anoxia | 5.42e-03 | 33 | 320 | 3 | C0003130 | |
| Disease | clear cell renal cell carcinoma (is_marker_for) | 5.42e-03 | 33 | 320 | 3 | DOID:4467 (is_marker_for) | |
| Disease | hemorrhoid | 5.48e-03 | 147 | 320 | 6 | EFO_0009552 | |
| Disease | Grey matter density measurement | 5.90e-03 | 34 | 320 | 3 | EFO_0010306 | |
| Disease | gait measurement | 6.03e-03 | 150 | 320 | 6 | EFO_0007680 | |
| Disease | gastric adenocarcinoma (is_implicated_in) | 6.04e-03 | 11 | 320 | 2 | DOID:3717 (is_implicated_in) | |
| Disease | glycerophosphorylcholine measurement | 6.04e-03 | 11 | 320 | 2 | EFO_0020018 | |
| Disease | primary angle closure glaucoma | 6.04e-03 | 11 | 320 | 2 | EFO_1001506 | |
| Disease | senile cataract (is_implicated_in) | 6.04e-03 | 11 | 320 | 2 | DOID:9669 (is_implicated_in) | |
| Disease | pulmonary fibrosis | 6.04e-03 | 11 | 320 | 2 | EFO_0009448 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SVVAGGDNYRVNNKH | 66 | Q9NWW9 | |
| NARYFHVVIAGESKD | 31 | Q5JXB2 | |
| LAKGQETDHRAGGYA | 1286 | Q86US8 | |
| NEYKGAVIVVSHDAR | 786 | Q8NE71 | |
| LQYGTAGFRTKAEHL | 21 | O95394 | |
| EAVDILKTERLGHGY | 226 | P00813 | |
| REYSNGQAGAIEHLK | 66 | Q6ZU80 | |
| HKGADSHAGVRYITE | 71 | Q7Z7A1 | |
| IESYQSRLAAAIGKH | 606 | Q5CZ79 | |
| NSLIAYGGNIDHKIS | 151 | Q96DX5 | |
| HIIKEYAENIGDGRS | 531 | Q8WYA6 | |
| LDHQKRGGARYTALD | 411 | P61201 | |
| DGAKQYRNGESVKLH | 576 | P0C0L5 | |
| YQTHAEGDIGKTGTI | 1671 | Q68DQ2 | |
| DLSGHKNIVGYIDSS | 96 | Q2M2I8 | |
| TKAYGERHEELINLG | 1286 | Q8N7X0 | |
| KGGGALEKESHRRSY | 1281 | Q96PE1 | |
| HQDGTSSVTEQGRYK | 436 | Q86TB3 | |
| VKVAIDTGYRHIDGA | 41 | P51857 | |
| YNGAIIVSGDEKDHR | 956 | Q8IUA7 | |
| RHSAEVAGYQDSIGQ | 346 | Q16352 | |
| VSRAEKGLYNEHTVD | 111 | Q6P6C2 | |
| SLFGQEVYSHLRKEG | 31 | Q3SY69 | |
| KSAGDTHGQVGTRRY | 351 | P27037 | |
| AEYQHSKGSGSEALV | 136 | P49640 | |
| QESIIKGSEHVAYGA | 306 | Q14832 | |
| LRGAGAIKADHVSTY | 26 | P20036 | |
| YTIHAEGDERGTKVT | 401 | Q4G176 | |
| YGILADATEQVGQHK | 11 | Q9BZZ5 | |
| GRIYGEVHDDLDQKT | 411 | Q8TF62 | |
| GDGRVVEGKHESYRI | 341 | Q9UIA0 | |
| RKTYDKEQSGDGSRH | 2191 | P20930 | |
| SKADGLAGSRHRYAE | 711 | P54253 | |
| GDLTENYRHLGFNKS | 361 | Q6ZW61 | |
| AQREGAKYVSHGATG | 106 | P00966 | |
| QEGDHGSHVYTKALL | 1136 | P01023 | |
| GNRLYREGHVKEAAA | 186 | O00170 | |
| GHTRNLFVYHESGKE | 206 | Q9NPF8 | |
| KATHGGRIDYIAGLD | 51 | P07741 | |
| RAVGVEYVKNGQSHR | 271 | Q8NE62 | |
| GQSHRAYASKEVILS | 281 | Q8NE62 | |
| KRIGYLAASQSFHEG | 91 | O14617 | |
| VKYFIRHGVEGSTDA | 341 | Q8N9B4 | |
| GGSLSVQCRYEKEHR | 36 | Q08708 | |
| SKNGRHVLGLIEDYE | 1721 | Q96SN8 | |
| VRLAFQVKGEHSYTG | 156 | P16260 | |
| GAYLDKERAVAQLHG | 381 | Q9UF12 | |
| SVQGGAHISTYDEKL | 426 | Q9HC84 | |
| DVESYDKIRAAGGHL | 1526 | Q9HC84 | |
| EHGVGKRKSSYTFEQ | 181 | Q6P1R3 | |
| GAGREVFDYSHRQKE | 186 | Q14494 | |
| VGKVRAVDADSGYNA | 591 | Q9Y5H5 | |
| GVGALEQEHAQYKRD | 786 | Q14644 | |
| GSYLGREVALDLSQH | 196 | O00391 | |
| VRVQLKDGSYHEDVG | 111 | P43351 | |
| IIKGDFNHTRGAGYV | 791 | Q8TE59 | |
| LEKGEAHREGLSYRT | 386 | Q6ZSG2 | |
| EVQKGRYSLHGSDRS | 501 | P23458 | |
| GEAYATKARAHGLEV | 26 | Q9BSH5 | |
| LESRYHQIGSGKCEI | 291 | O14979 | |
| RGGDHRVELYKVLSS | 181 | Q8N2K0 | |
| SAGKLTQYTVEDGGH | 901 | O00763 | |
| NDGKYHLADSLVTGI | 521 | Q9UJX4 | |
| SIVEDIHQGKSEHYG | 191 | Q9C0D6 | |
| IHQGKSEHYGSETLR | 196 | Q9C0D6 | |
| TTNGATARKYAHLVD | 451 | Q02252 | |
| TARKYAHLVDVGQVG | 456 | Q02252 | |
| RAHYETEGSRGAVKA | 421 | Q13469 | |
| VGSGQLHYSVSEEAK | 26 | Q9Y5I1 | |
| SYDTGDKALQCGRHV | 436 | Q05329 | |
| EYGAERKISRHSVLG | 336 | Q9NVH1 | |
| EQYKHLRQRDGSGVT | 596 | Q14566 | |
| VGSGQLHYSVSEEAK | 26 | Q9Y5H8 | |
| LKEYADNLTNSGVHG | 626 | Q674X7 | |
| QGLGLYAARDIEKHT | 4781 | Q8NEZ4 | |
| LEGEIGKDVSTSYRH | 976 | Q5TCQ9 | |
| VNNGSLSYDHSKDGR | 181 | Q12907 | |
| SSHVQRGYGKVQAEF | 161 | O76036 | |
| KYVAHSGIGDRSVSL | 386 | Q86UX2 | |
| KQQDGELVGYRISHV | 411 | Q12866 | |
| IGSHDVYKVETIGDA | 916 | Q02846 | |
| HGAGEQYRGTVSKTR | 356 | Q2TV78 | |
| KLSDYGISRQSFHEG | 1406 | Q38SD2 | |
| IKDSGLRFHYVAAGE | 76 | Q8IUS5 | |
| HLSTIDYVEDGKGIR | 416 | Q9BZ67 | |
| LKVYGGDDRIGALTH | 121 | Q16775 | |
| SDIGSGIRYLHENKI | 126 | O15111 | |
| DTYRGAKIVHVSLDG | 1321 | O60303 | |
| VDRQGAHIVGYFSKE | 291 | Q9H7Z6 | |
| ENQAGVLHVGRVYKE | 196 | A6NMX2 | |
| YEELQVTAGKHGDNL | 341 | Q5XKE5 | |
| DNANRGIGKRSVEYH | 3021 | Q5SZK8 | |
| KDGHVYTFGQDRLIG | 4256 | Q15751 | |
| GGNYSRHRAQTEKHV | 341 | Q5JUK3 | |
| VDREGGLNTVKYHVA | 281 | Q9UBV7 | |
| LNGVHDRAYVAVDGI | 436 | P16278 | |
| GIIAANVEKHYETGR | 346 | Q9C098 | |
| NVEKHYETGRVIGDG | 351 | Q9C098 | |
| IGKNTFKYRGQDGTH | 316 | Q5CZC0 | |
| ITETSINGHGAYGEK | 411 | P12107 | |
| YDTGDKAIQCGRHVD | 446 | Q99259 | |
| HQVVCGSKYLVRGES | 1066 | Q12766 | |
| GSKYLVRGESARDHV | 1071 | Q12766 | |
| LKRVEYGAEGRHNST | 281 | Q8N441 | |
| KYEELQITAGRHGDS | 376 | P04264 | |
| LQGSYAGKIHSIGDA | 31 | Q1X8D7 | |
| IYVSKVDHGGLAEEN | 236 | Q9H5P4 | |
| DGRINHGRIAYISSK | 776 | Q13370 | |
| GVVRYEHANDDKSSL | 521 | Q6P996 | |
| RSNIKIHEDANGGIY | 171 | O75037 | |
| GDLHTLKVRYQHDGT | 841 | Q5H8C1 | |
| DVDSKNVAYRHSGGD | 1571 | Q5H8C1 | |
| VSVLHGNRGVYHDDK | 356 | A0PJZ3 | |
| QRNGLILHTGKSADY | 291 | Q9Y4C0 | |
| EYNGHVDKAIESRTV | 1746 | Q9HD67 | |
| RALIGDDVGLTSYKH | 316 | Q53F19 | |
| VLTVHSYAKGDGRVT | 541 | O75164 | |
| TADGGKHVAYIIRSH | 96 | P31025 | |
| NKYTGEGLREIHSDI | 251 | O75581 | |
| YRLALKDGHGTAISN | 121 | O60449 | |
| YDNHIKSSVVGSERK | 241 | Q9Y6K9 | |
| GYLSVGSRKEHGTAL | 16 | P50748 | |
| GSRKEHGTALYQVDL | 21 | P50748 | |
| QVGAGQTFEYLKREH | 41 | Q9H0V9 | |
| GNVKVSRELSAHTGY | 131 | P16520 | |
| LSTGKYLNVVRECGH | 451 | Q9BSJ2 | |
| NGEKINYTEGRAVLH | 86 | P06744 | |
| VDAEYLKVGSEGHFR | 86 | Q6UWW0 | |
| HGAYKVRIAVLSDGT | 396 | Q9HCJ2 | |
| GSQEAQEYRLHKEGS | 51 | O75022 | |
| YDGIQRKTVVHGGSL | 586 | P98164 | |
| HGDIRYRKTLIANDG | 1851 | P98164 | |
| HGGDKETYNNIIRSG | 2136 | P98088 | |
| KSGGNYSRHRAQTEK | 286 | Q6UVM3 | |
| TSGESLYHVLGLDKN | 11 | Q9H3Z4 | |
| NVKYGIVLDAGSSHT | 46 | P49961 | |
| RGYGDKTEATTKLHD | 1021 | A2RRP1 | |
| QHYGRSLTKETIKDG | 196 | Q8NFU5 | |
| NLFEGRGYEKSVIHS | 711 | Q9GZU2 | |
| GLHYQESDGKAQVTG | 3116 | Q9UPN3 | |
| LAESVYRALKEQGGH | 1336 | P29475 | |
| HLKRGNVEHGDSSAY | 111 | Q8IV76 | |
| TGDIHAKQILDYENG | 2831 | Q6V1P9 | |
| GSGVSILAVHSKDNY | 191 | Q9H999 | |
| TKGERDLIYAFHGSR | 141 | Q8N5Y8 | |
| VYRSKSVGHEPNSED | 591 | Q86SP6 | |
| GSYTEKDASHLVGQV | 106 | Q6P2M8 | |
| TAQEYGGIIRHGAKL | 401 | P05166 | |
| GSYRLGVHTKGADID | 101 | P51003 | |
| TSHRETQKAYLLAAG | 246 | Q8NA29 | |
| GAGVKKRRHGDEDTY | 341 | O15350 | |
| SYRLGVHTKGADIDA | 101 | Q9BWT3 | |
| VDYGDISSRVGLRHK | 391 | Q10472 | |
| YDLLVNEISHIGSRG | 316 | Q13315 | |
| TLEHLNGAYKVEEGD | 431 | Q08462 | |
| GHYILNGKGEEAKSR | 761 | O15072 | |
| RGEYRTEEGLVKGHA | 246 | Q6ZSI9 | |
| FGISGVQKYTRALHD | 96 | O95760 | |
| GLGGAAASSHRDIYK | 166 | Q9P2D3 | |
| HNILRESGYAGKISQ | 596 | P49915 | |
| YISGGITHDTFQKEL | 491 | Q9P2N7 | |
| GGRSGETVKHEISYR | 336 | O15234 | |
| HSGGRVKDIQSVYLD | 151 | Q96SD1 | |
| EHEKYGVVIASFRGT | 6 | Q8N1I0 | |
| TLQDGRHDLVVYKGD | 561 | Q9H7D0 | |
| RLGSGFHIKYEELSQ | 91 | Q96LM5 | |
| AGVFHVEKNGRYSIS | 31 | P16070 | |
| IGTAKHGLNRTDCYI | 1586 | Q8TD26 | |
| KHKYSGETRQSNGAR | 201 | Q8TD84 | |
| TIANRCHEGGQSYKI | 136 | P02751 | |
| AGTVLQEASYKGHRA | 211 | Q92828 | |
| RLHSDIDSGDGNIKY | 76 | P55287 | |
| HGLTYGVIRVDSEEK | 681 | Q9Y2E4 | |
| HSSGGKALAQREFYT | 371 | Q9UHN6 | |
| LGSNLHVEVKGYEDG | 146 | P78410 | |
| ASDGEVRRGYHKVSL | 26 | Q8WXX5 | |
| GTYTTHAQIKKGNRE | 521 | Q9NTJ4 | |
| LERLGTGGAYEVKQH | 826 | O15021 | |
| KDTNIYLAGTEEGHI | 671 | Q5VTH9 | |
| LTRTHINYGVKGDVA | 36 | P40939 | |
| SHIRYEVDVSAGNGA | 176 | P19235 | |
| SSEAVQYAVRGDGGK | 396 | Q96J84 | |
| YEDGHGSRKNITDLV | 191 | Q8IWA5 | |
| KLHSDQDRGDGSLKY | 76 | P55285 | |
| TAGILTRKNGYNRHE | 546 | P55285 | |
| KGTNRISYAVQGAHE | 446 | O00423 | |
| AGVGVVYNTREHSQK | 41 | Q6ZMW3 | |
| HPVKDYVATGQVGRD | 736 | Q6ZMW3 | |
| SRRHYGESITNIGKA | 731 | Q8NEL9 | |
| YVAVNRSHGQLKTDE | 321 | P35367 | |
| DHASNIYKVEGGCIT | 196 | P48509 | |
| GYRSQDKSFHVEGAL | 176 | Q9BRP7 | |
| DSTHGRYKGSVEFRN | 121 | O14556 | |
| EGLGSHDRAIKYLNQ | 16 | P17655 | |
| DAGSYTLHIIKRRDG | 116 | Q00888 | |
| DAGSYTLHIIKRGDG | 116 | Q9UQ72 | |
| VKNIDDGTSDRPYSH | 26 | P61353 | |
| GQAGRHIYKSLADDG | 6 | Q9UMX9 | |
| QYKGISRSHGEITEE | 201 | Q9P1Z2 | |
| ELTRAASDYAGKQAH | 886 | P28340 | |
| KQKTDVHYRSLGGEG | 1851 | O75923 | |
| RITHGFKLQSAYESG | 461 | Q9ULM6 | |
| EEYLASLGRKHRAVG | 86 | Q9NPG2 | |
| LATAYIHRFTNGGKE | 21 | O15239 | |
| YHTKVRAGRGFSLEE | 66 | P26373 | |
| DDTVTYSALHKRQVG | 791 | P20273 | |
| DGAKQYRNGESVKLH | 576 | P0C0L4 | |
| LKGRYIGELDQSHFT | 346 | Q9NT99 | |
| SIGLVSFGEHYKRNE | 486 | Q05469 | |
| SFGEHYKRNETGLSV | 491 | Q05469 | |
| YEEAKHGTFVGRIAQ | 36 | Q9UN75 | |
| DAGSYTLHIVKRGDG | 116 | Q16557 | |
| TAYGKTGIRDVHLEL | 281 | Q8TE04 | |
| NGTQEHTKVRLSVYG | 1006 | P33527 | |
| NFTKEITHYIRGGEA | 731 | Q9Y6R4 | |
| ITHYIRGGEAQAGKL | 736 | Q9Y6R4 | |
| EYDHDANGERVVLGK | 646 | Q6ZN16 | |
| DLINGRVAYAHTAGE | 1011 | P0C091 | |
| RIIHGSGYSDEDRKG | 56 | O95837 | |
| KNGLEFDTGIHYIGR | 111 | Q6NUM9 | |
| HASTANGESRAIKIY | 196 | Q9BRS2 | |
| NGAEGASNSKLYRRH | 351 | Q59EK9 | |
| RAGKQGQHAVSAYLA | 1051 | Q9NZ71 | |
| KVFVGYNSTGAELRH | 376 | P21579 | |
| DLASGTLYKELRGHT | 496 | O75529 | |
| AVRVHVSYLDGKGNL | 126 | Q9Y6J9 | |
| EDDVYGNSSGRKHRG | 201 | Q8IUI4 | |
| QAGEVTYADAHKGRK | 126 | Q08170 | |
| TYADAHKGRKNEGVI | 131 | Q08170 | |
| EIVSVYASAAKHGGE | 456 | Q68CR1 | |
| NSIATTKGGRHVDYV | 336 | Q02880 | |
| IRNVTFGGKAYLDHN | 276 | Q9BXR5 | |
| VHSLERAGSKQYSAA | 366 | Q9UPR3 | |
| NYLECQKGEDTGRVH | 451 | Q5HYK7 | |
| FSIKLSETHGYGVQE | 1406 | Q8WXH0 | |
| HAEVTYRVSGQKAAA | 336 | O75354 | |
| YRVSGQKAAASLHEL | 341 | O75354 | |
| DGHILDSKRYAVIGA | 156 | Q9UIC8 | |
| EYLVAGHEDIRTGKL | 586 | Q9HB63 | |
| GNKASYIHLQGSDLR | 456 | P53041 | |
| DAGTYTLHIIKRGDE | 116 | Q00887 | |
| DSHAEVISGKQEGVY | 211 | Q9Y227 | |
| ISFILYGNSHRTGKD | 866 | Q96Q15 | |
| TVGGEARKVYDDAHN | 1001 | Q99707 | |
| GEKARGYEESEGHNT | 746 | Q8TE76 | |
| SVGIHYLVAKGTADD | 826 | Q9NZC9 | |
| RRLHYGENGVQKDVS | 296 | P04279 | |
| RRLHYGENGVQKDVS | 356 | P04279 | |
| SALERLYSGDHQRGK | 1056 | Q6IQ23 | |
| GYAEVINAGKSRHNE | 106 | Q5JR12 | |
| SKQEYDESGPSIVHR | 1021 | P0CG39 | |
| RVHADIQNDEKGGYS | 71 | Q6P435 | |
| GSDHEYQVNGKRILG | 501 | Q9UHD8 | |
| YLDSGALDGTHRVKL | 36 | Q16842 | |
| LIDVFHQYSGREGDK | 11 | P04271 | |
| EGNGSHTIRDLKYTI | 166 | Q7KZF4 | |
| HGLYRTTGASFEKAQ | 286 | O15126 | |
| KYELISETGGSHDKR | 526 | Q96SI9 | |
| VTGADYIVKIFDRHG | 31 | Q8NEZ3 | |
| DQYRRHSLFGTGKDQ | 996 | Q14191 | |
| YHSSIGVRKDELVHG | 836 | Q13017 | |
| GNIIITKYEQGHRAG | 16 | Q86UD7 | |
| TKYEQGHRAGAAVDL | 21 | Q86UD7 | |
| VGIGTSDVDLDKYRH | 166 | Q6PJ21 | |
| LSSADYVERGQEHVK | 246 | Q12846 | |
| VTYADAHKERTNEGV | 136 | Q13247 | |
| RAGHQEKEQYSRLSG | 151 | Q8TAV0 | |
| RGNETLHYETFGKAA | 151 | P13598 | |
| ASYVLGIGDRHSDNI | 911 | P42338 | |
| DTGSYTLHIIKRGDG | 116 | Q13046 | |
| EGSQEYNEGLVKRLH | 816 | Q6ZRS2 | |
| KSHDNVYSLGGLEGR | 156 | Q86SQ0 | |
| VFAENGTVQYKHGRL | 76 | Q92871 | |
| GKKRHTDVQFYTEVG | 731 | Q9Y5B9 | |
| ITKGDLSYLDQGHRD | 1051 | Q9NRY4 | |
| LSYLDQGHRDGQRKS | 1056 | Q9NRY4 | |
| YDLDKTLGRGHFAVV | 16 | Q9NRH2 | |
| AKHGLINAGYRAIDS | 756 | Q9UL12 | |
| YKDGDIHRGFQSLLS | 61 | P50452 | |
| GTHEVRYVSAGQSVA | 71 | Q96BD0 | |
| LHGLESQIQSDDYGK | 1396 | Q01082 | |
| HGYDTQVGERGLKLS | 596 | O75027 | |
| ELERQLKESGYCTGH | 286 | O00116 | |
| DHIQTIDSLLRKGGY | 266 | Q9Y4X0 | |
| QYHAVEKASTGLGIR | 461 | Q9H6Q4 | |
| LVHLGEYQAAVDGAR | 1231 | Q00610 | |
| GAVGEAVSREKQHIY | 91 | Q9NS84 | |
| SQYERQGEIKTSLHG | 171 | Q8NA57 | |
| SEGRITHGFQLKSAY | 456 | Q96LI5 | |
| EKRATYVHKDGLNST | 3091 | A4UGR9 | |
| EHGPVSEAKSNRRVY | 3166 | A4UGR9 | |
| IAQGKADYRQVLGHT | 571 | O95985 | |
| VLFYIRSHDVKNGGE | 406 | Q9H9J4 | |
| EGGHLATYKQLEAAR | 61 | P98066 | |
| RQKTHTGERSYECGE | 741 | O43361 | |
| SGVNTRYQEQGAKLH | 2446 | Q8N2C7 | |
| NDAFTHVYSGGRDRK | 261 | Q8TAF3 | |
| QLVIKGARDSHAGLY | 101 | Q8WVN6 | |
| EGENCRYSHDLSGRK | 111 | Q13064 | |
| YGQALAKLGHASDRI | 321 | P29401 | |
| KGANTHYFRDGDLVT | 196 | P41226 | |
| HKYSEEGGLINESLR | 401 | Q9HCF6 | |
| LIAAGHYAKGDISSR | 1511 | Q13813 | |
| RVAVEHSYRKAEEGG | 176 | Q6ZN55 | |
| HSYRKAEEGGEGATV | 181 | Q6ZN55 | |
| LGYHKDSSEGNVAVE | 16 | Q5SVQ8 | |
| GEDIRSQKSHYKSGE | 201 | Q3SY52 | |
| GQEYNVLLTAEKGRH | 1046 | P24821 | |
| LIRHQGIHSGEKTYE | 121 | Q6AZW8 | |
| YRGSLKEHQRIHSGE | 451 | Q9BUG6 | |
| EVHIGLVDKNYGSSS | 521 | Q9HCK1 | |
| ARISGYNIRHAKGEN | 1241 | Q8IWV7 | |
| GKAFSDGSYLVQHQR | 571 | Q6ECI4 | |
| RSGLRKGHENEESAY | 191 | Q02094 | |
| EGAAQLRTVYAGEHA | 1896 | Q9H254 | |
| VSLGVSERAEYHGKN | 491 | Q6UXZ4 | |
| DYGHGRDISTNKVEQ | 1641 | P49750 | |
| DYVAVARGSKDHNIR | 4076 | P78527 | |
| SASLEVYGKEGLVHS | 361 | Q9UBD6 | |
| EVHKGGYSEVNQCLS | 136 | Q96JC4 | |
| QKSYLSGHERIHTGE | 781 | Q5TYW1 | |
| THIGEKSDVAEAGYV | 891 | Q9BY31 | |
| KGGRHVDYVADQIVT | 321 | P11388 | |
| GAQGLYFHIGETEKR | 26 | Q7Z7H5 | |
| GKRVHSFGGEYLVSV | 581 | Q9H967 | |
| GNIIITKYEQGHRAG | 16 | Q2M2D7 | |
| TKYEQGHRAGAAVDL | 21 | Q2M2D7 | |
| GHDELSRGTRNYKKT | 291 | Q96DT7 | |
| DAGSYTLHIIKRGDG | 116 | P11465 | |
| FDLHRYVIGQKGSGI | 981 | Q00341 | |
| SRAKLYVDAAVHGTT | 2736 | Q70CQ2 | |
| QKRHGISSQRFYGEA | 176 | Q53EQ6 | |
| GQVYHLTVEGNSVKD | 686 | Q9BZH6 | |
| YSGLIEHQRVHSGEK | 191 | O75123 | |
| HGECGKKQVSYRTDI | 131 | Q9HB21 | |
| DVVICYERAGQHGKA | 471 | Q6P3X3 | |
| HVKAGFQGRRSYSEL | 451 | A7MCY6 | |
| DAGSYTLHIIKRGDR | 116 | Q15238 | |
| GGADGRVHTKEAIAY | 151 | A8MYJ7 | |
| SRCTKEEAIEHNYGG | 486 | Q93009 | |
| KDRVTGQHQGYGFVE | 46 | Q15427 | |
| GSSIHLYNTRRGEKE | 351 | Q9Y4P3 | |
| LAQGEYEKGVDHLTN | 81 | Q15388 | |
| EGTGRAADLLAYIHK | 316 | Q96QT4 | |
| RANKVYHAGEVLSGV | 11 | O14972 | |
| ASGYHSEGETLKEKQ | 476 | Q70EL1 | |
| VGKHYLQLAGDTDEE | 106 | O76024 | |
| QKSYLSGHERIHTGE | 541 | Q4V348 | |
| LATIRAYLNQKGEGH | 626 | P23378 | |
| VGTYHFRLTVKDQQG | 686 | Q5VV43 | |
| LFGTVKYGENINRHA | 1356 | Q8IZF0 | |
| AADRRDAFVKGIYGH | 391 | Q6PIF6 | |
| HTVTYGNIEGNAAKR | 1066 | Q13224 | |
| KGHYVGTLTARDDNK | 4016 | P20929 |